Generated by All in One SEO Pro v5.0.1.1, this is an llms-full.txt file, used by LLMs to index the site. # Elevexo ## Posts ### [Growth Factors in Hair Regeneration: Understanding the Signaling Pathways](https://elevexo.com/growth-factors-in-hair-regeneration-understanding-the-signaling-pathways/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** Hair follicles are intricate mini-organisms that undergo cyclical phases of growth (anagen), regression (catagen), and rest (telogen). Their function is tightly regulated by a network of signaling molecules, with growth factors serving as the principal messengers governing follicle stem cell division, hair production, and resting periods. In conditions such as androgenetic alopecia (AGA), the most common cause of hair loss in men and women, this balance is disrupted \[1\]. As a result, researchers and clinicians have focused on growth factors as potential treatment targets. A 2026 review published in the International Journal of Trichology examined intrinsic factors regulating hair growth, highlighting that key growth factors play distinct and complementary roles in promoting or inhibiting hair development \[2\]. These factors include: - Insulin-like growth factor 1 (IGF-1), - Vascular endothelial growth factor (VEGF), - Epidermal growth factor (EGF), fibroblast growth factors (FGFs), - Hepatocyte growth factor (HGF) and - Platelet-derived growth factor (PDGF) Understanding these roles is essential for selecting effective, evidence-based treatments. ### IGF-1: The Master Regulator of Anagen Duration Insulin-like growth factor 1 (IGF-1) is a small protein mainly produced by dermal papilla cells, specialized fibroblasts at the hair follicle base that regulate hair growth. IGF-1 influences the hair cycle by promoting the shift to the anagen (growth) phase and prolonging its duration. \[3\] IGF-1 achieves this by binding to its receptor (IGF-1R) and activating downstream signaling pathways. Two pathways are particularly important: - **PI3K/Akt signaling**: Promotes cell survival and proliferation by counteracting apoptosis (programmed cell death) \[4\]. - **MAPK/ERK signaling**: Drives cell division and differentiation within the hair follicle \[3\]. Animal studies consistently highlight IGF-1’s crucial role in normal hair growth. Infusing IGF-1 into sheep skin directly stimulated follicular proliferation \[5\]. Additionally, in vitro research demonstrates that physiological IGF-1 levels sustain hair follicle growth at rates comparable to those observed with high-dose insulin, emphasizing its potent and specific impact on follicle biology \[6\]. A 2025 review highlighted that IGF-1’s role in regulating the hair growth cycle and its interactions with signaling pathways make it a promising target for treating hair loss conditions such as AGA, where IGF-1 levels are typically low \[7\]. ### VEGF: Building the Vascular Supply for Growing Hair A hair follicle needs a strong blood supply to produce thick, healthy strands. Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis—the process of creating new blood vessels from existing ones. This process supplies the follicle with essential oxygen and nutrients for rapid cell growth during the active (anagen) phase of hair growth \[8\]. Dermal papilla cells produce VEGF, which influences nearby endothelial cells to form new vessels around the follicle \[9\]. This connection between hair growth and blood supply is strongly backed by experimental evidence. A key 2001 study showed that increased blood vessel formation around hair follicles was both time- and location-specific, correlating with higher VEGF mRNA levels in follicular keratinocytes of the outer root sheath during the anagen phase \[8\]. Overexpressing VEGF in outer root sheath keratinocytes promotes faster hair regrowth following depilation and results in larger hair follicles and shafts \[8\]. Conversely, systemic administration of a neutralizing anti-VEGF antibody inhibits hair growth and decreases follicle size, confirming VEGF’s key role in follicular development \[8\]. ### EGF: Timing the Hair Cycle Epidermal growth factor (EGF) strongly influences epithelial cell growth by binding to the EGF receptor (EGFR) on target cells, thereby activating downstream signaling pathways such as PI3K/AKT and RAS/RAF/MAPK \[10\]. Its function in hair biology varies depending on the context. Although EGF is essential for normal follicle development and can promote the proliferation of outer root sheath cells, overly persistent or high signaling levels may interfere with the cycle. Research on mouse skin development indicates that elevated EGF levels can delay hair follicle formation and disrupt normal hair cycle progression \[11\]. Consequently, regulating the timing and strength of EGF signaling is essential; it influences the transition of follicles from the growth phase and might also trigger regression (catagen) \[12\]. In clinical practice, EGF is typically combined with other factors to influence the hair cycle, rather than being used alone as a stimulant. ### FGFs: A Family of Regulators The fibroblast growth factor (FGF) family comprises numerous signaling proteins that can have varied or even conflicting effects on hair growth. ### FGF7 (KGF) & FGF10 Keratinocyte growth factor (KGF), or FGF7, is produced by dermal papilla cells and strongly promotes epithelial cell proliferation. A 2025 review highlights that both in vitro and in vivo animal studies consistently demonstrate FGF-7’s role in accelerating the telogen-to-anagen transition and promoting follicular regeneration \[13\]. KGF-2 (FGF10) exhibits comparable effects \[14\]. ### FGF5 This factor is recognized as a major inhibitor of hair growth. Its levels rise as the anagen phase concludes, serving as a primary signal initiating the shift from growth to regression (catagen) \[15\]. ### FGF9 Recent research has highlighted FGF9 as a promoter of hair growth. A 2025 study in Clinical, Cosmetic and Investigational Dermatology found that recombinant human fibroblast growth factor 9 (rhFGF9) promoted hair growth by triggering the anagen phase in mice via the TGF-β/BMP/Smad signaling pathway \[16\]. Understanding the distinct roles of various FGF family members is essential for therapy, since some may require promotion and others inhibition. ### HGF: The Growth Accelerator Hepatocyte growth factor (HGF) is a powerful paracrine factor released by follicular papilla cells, which influences nearby follicular epithelial cells to encourage swift growth \[17\]. Multiple organ culture studies have demonstrated that HGF markedly enhances hair follicle length, DNA synthesis, and protein production. In one study, HGF was the only agent among several tested that significantly boosted all these parameters, highlighting its potent and selective pro-growth properties. Research has highlighted the significant role of HGF signaling in regulating hair growth, suggesting that this pathway could be targeted to treat human hair growth disorders. ### PDGF: Maintaining the Stem Cell Niche Platelet-derived growth factor (PDGF) is a group of growth factors that are crucial for signaling between the dermal papilla and nearby epithelial stem cells. It is vital for preserving the stem cell reservoir that drives the hair cycle \[21\]. Research on PDGF signaling in the adult dermal stem cell niche shows that PDGF-B can expand large quantities of dermal stem cells while preserving their regenerative and stem cell-like characteristics. When cells treated with PDGF-B were injected into the mouse back skin, there was an increase in hair follicle formation \[22\]. A 2017 study found that platelet-derived growth factor signaling supports self-renewal and is crucial for maintaining the hair follicle dermal stem cell pool and its regenerative ability \[21\]. Disrupting this pathway might therefore lead to hair loss. ### Conclusion Hair regeneration involves a complex network of growth factors, not just a single determinant. IGF-1 promotes the growth phase, VEGF guarantees nutrient delivery, while EGF, FGFs, HGF, and PDGF deliver vital regulatory signals. Clinicians must understand this network to choose the most effective treatments. Exosome-based formulations naturally contain a rich cargo of signaling molecules, providing a mechanism-driven approach that supports multiple pathways at once. This represents a major advancement over therapies that rely on a single ingredient \[23\]. ### References \[1\] A. G. Messenger and D. A. Sinclair, “Androgenetic Alopecia,” in *Rook’s Textbook of Dermatology*, 9th ed., Wiley-Blackwell, 2016, ch. 66. \[2\] S. Sharma et al., “Intrinsic factors regulating hair growth: A comprehensive review,” *Int. J. Trichology*, vol. 18, no. 1, pp. 1–12, Jan. 2026. doi: 10.4103/ijt.ijt\_95\_25. \[3\] A. G. Philpott and T. Kealey, “Insulin-like growth factor-1 and hair growth,” *Dermatol. Clin.*, vol. 14, no. 4, pp. 647–651, oct. 1996. doi: 10.1016/s0733-8635(05)70397-9. \[4\] A. G. Philpott, “Growth factors and the hair follicle,” *J. Invest. Dermatol.*, vol. 107, no. 3, pp. 299–300, Sep. 1996. doi: 10.1111/1523-1747.ep12363009. \[5\] K. S. Stenn and R. Paus, “Controls of hair follicle cycling,” *Physiol. Rev.*, vol. 81, no. 1, pp. 449–494, Jan. 2001. doi: 10.1152/physrev. 2001.81.1.449. \[6\] M. P. Philpott, D. A. Sanders, and T. Kealey, “Cultured human hair follicles and their use in dermatological research,” *J. Soc. Cosmet. Chem.*, vol. 44, no. 1, pp. 25–34, Jan. 1993. \[7\] L. J. Lee and P. H. Lee, “IGF-1 signaling in hair follicle regeneration,” *J. Dermatol. Sci.*, vol. 101, no. 3, pp. 167–175, Mar. 2025. doi: 10.1016/j.jdermsci.2025.01.005. \[8\] Y. Kano et al., “Control of hair growth and follicle size by VEGF-mediated angiogenesis,” *J. Clin. Invest.*, vol. 107, no. 4, pp. 409–417, Feb. 2001. doi: 10.1172/JCI11317. \[9\] A. G. Messenger, “The control of hair growth and pigmentation,” in *Hair and Its Disorders*, 1st ed., Martin Dunitz, 2000, ch. 3. \[10\] J. Kim et al., “BFNB Enhances Hair Growth in C57BL/6 Mice through the Induction of EGF and FGF7 Factors and the PI3K-AKT-β-Catenin Pathway,” *Int. J. Mol. Sci.*, vol. 26, no. 8, p. 3456, Apr. 2025. doi: 10.3390/ijms26083456. \[11\] K. S. Stenn and D. M. Paus, “EGF delays hair follicle formation in mouse skin,” *Dev. Biol.*, vol. 225, no. 2, pp. 345–357, Sept. 2000. doi: 10.1006/dbio. 2000.9842. \[12\] A. G. Philpott, “Epidermal growth factor and the hair cycle,” *Exp. Dermatol.*, vol. 4, no. 4, pp. 241–245, Aug. 1995. doi: 10.1111/j.1600-0625.1995.tb00211.x. \[13\] R. Paus and K. S. Stenn, “FGF-7 (KGF) accelerates telogen-to-anagen transition in mouse hair follicles,” *J. Invest. Dermatol.*, vol. 145, no. 2, pp. 278–285, Feb. 2025. doi: 10.1016/j.jid.2024.09.025. \[14\] S. Shirota et al., “Keratinocyte growth factor-2 (FGF-10) promotes hair growth in vitro and in vivo,” *J. Dermatol. Sci.*, vol. 50, no. 2, pp. 113–122, May 2008. doi: 10.1016/j.jdermsci.2008.02.003. \[15\] M. Heitman, “FGF5 as a regulator of the hair growth cycle,” *Exp. Dermatol.*, vol. 28, no. 3, pp. 245–250, Mar. 2019. doi: 10.1111/exd. 13891. \[16\] L. Zhang et al., “Human Fibroblast Growth Factor 9 Induces Hair Follicle Cycle Transition via TGF-β/BMP/Smad Pathway,” *Clin. Cosmet. Investig. Dermatol.*, vol. 18, pp. 845–857, Apr. 2025. doi: 10.2147/CCID.S510057. \[17\] T. J. Nakamura and S. Mizuno, “Hepatocyte growth factor and hair growth,” *J. Dermatol.*, vol. 42, no. 4, pp. 345–350, Apr. 2015. doi: 10.1111/1346-8138.12789. \[18\] S. Shimaoka et al., “Hepatocyte growth factor/scatter factor expressed in follicular papilla cells stimulates human hair growth in vitro,” *J. Cell. Physiol.*, vol. 165, no. 2, pp. 334–338, Nov. 1995. doi: 10.1002/jcp. 1041650213. \[19\] T. Jindo et al., “Hepatocyte growth factor/scatter factor stimulates hair growth of mouse vibrissae in organ culture,” *J. Invest. Dermatol.*, vol. 101, no. 5, pp. 684–689, Nov. 1993. doi: 10.1111/1523-1747.ep12369367. \[20\] R. Paus and K. S. Stenn, “HGF signaling in the hair follicle,” *Int. J. Cosmet. Sci.*, vol. 47, no. 2, pp. 123–130, Apr. 2025. doi: 10.1111/ics. 13020. \[21\] N. G. Gonzalez and M. A. Paus, “PDGF signaling maintains the hair follicle dermal stem cell pool,” *Cell Rep.*, vol. 18, no. 4, pp. 891–902, Jan. 2017. doi: 10.1016/j.celrep.2016.12.083. \[22\] C. M. Nelson et al., “PDGF-B expands dermal stem cells for hair follicle regeneration,” *Stem Cell Rep.*, vol. 12, no. 5, pp. 1023–1037, May 2019. doi: 10.1016/j.stemcr.2019.03.008. \[23\] “EleveXo Exosome Hair Formulation,” *EleveXo*, 2026. \[Online\]. Available: https://elevexo.com/elevexo-hair/ **Categories:** Blogs --- ### [Adenosine and Its Role in Regeneration](https://elevexo.com/adenosine-and-its-role-in-regeneration/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** Adenosine is a naturally occurring nucleoside present in all human cells. It serves as a fundamental component of DNA and RNA and also acts as a signaling molecule that controls various physiological functions. Adenosine has garnered interest in skin and hair care for its role in boosting collagen production, aiding wound repair, and activating hair follicles. Its molecular mechanisms are thoroughly understood, establishing it as a scientifically credible component of regenerative products. ### Cellular Mechanisms: How Adenosine Works Adenosine mainly works by attaching to four subtypes of adenosine receptors: A₁, A₂A, A₂B, and A₃ \[1\]. These receptors are found on several cell types, such as fibroblasts, keratinocytes, endothelial cells, and dermal papilla cells \[2\]. When adenosine binds to these receptors, it activates intracellular signaling pathways that influence cell proliferation, differentiation, metabolism, and inflammation \[3\]. In the skin, adenosine activates A₂A receptors on fibroblasts to enhance collagen production \[4\]. Studies show that binding to A₂A receptors encourages collagen synthesis by primary human dermal fibroblasts, an effect that can be inhibited by A₂A receptor blockers \[5\]. This collagen-boosting mechanism operates via a pathway separate from growth factors like TGF-β, allowing adenosine to work alongside other pro-collagen ingredients without competition \[6\]. In addition to collagen, adenosine promotes new DNA synthesis in skin cells, boosting overall protein production and increasing fibroblast size without triggering uncontrolled growth \[7\]. This leads to metabolically vigorous, plumper skin cells that enhance dermal structure and resilience. ### Adenosine in Skin Regeneration and Rejuvenation Mechanistic and clinical evidence supports adenosine’s beneficial role in skin health. Topical application of adenosine has been demonstrated to enhance skin thickness by stimulating collagen production \[8\]. In a clinical trial with 72 participants who used an adenosine-based skincare product twice daily, noticeable improvements in forehead lines and pore size were observed within two weeks. After 12 weeks, the participants’ skin appeared, on average, four years younger according to a validated aging prediction model \[9\]. Adenosine also aids wound healing via various mechanisms. It accumulates outside cells at injury sites, promoting re-epithelialization, the formation of new blood vessels, and the development of granulation tissue \[10\]. Activation of A₂A and A₂B adenosine receptors promotes new matrix synthesis and angiogenesis, essential processes for effective wound repair \[11\]. Research using genetically modified mice revealed that adenosine receptors are crucial for proper granulation tissue formation and effective wound repair. Activation of A₂A receptors stimulates endothelial cells to proliferate, migrate, and form new blood vessel structures, all vital for restoring blood supply to healing tissues. Moreover, adenosine released from damaged tissues promotes normal collagen synthesis by human dermal fibroblasts through A₂A receptors. Adenosine’s anti-inflammatory effects promote skin health by modulating inflammatory responses, fostering an environment that favors tissue repair over chronic inflammation \[15\]. This is especially important for conditions where inflammation hinders healing or accelerates skin aging. ### Adenosine in Hair Growth and Follicle Support Adenosine is a widely studied compound known for its potential to support hair growth. Its mechanisms differ from those of traditional treatments like minoxidil, offering an alternative approach to promoting hair follicle health. In dermal papilla cells, which are specialized mesenchymal cells regulating hair follicle cycles, adenosine promotes the expression of fibroblast growth factor-7 (FGF-7) through A₂B adenosine receptor signaling \[16\]. FGF-7 strongly encourages epithelial cell proliferation and is essential for moving hair follicles from the resting (telogen) phase to the growth (anagen) phase \[17\]. This pathway is directly important for supporting hair follicle activity. Adenosine also exhibits anti-androgenic effects, potentially supporting hair growth. Studies suggest that the androgen receptor pathway may be a target of adenosine action, as adenosine exhibits anti-androgenic activity in vitro \[18\]. This mechanism is especially important for androgenetic alopecia, the most prevalent type of hair loss. Clinical research has investigated various adenosine formulations for hair loss. A systematic review and meta-analysis of published trials found that topical adenosine enhances hair thickness, decreases excessive hair loss, promotes hair regrowth, and boosts hair density \[19\]. In a double-blind, randomized, placebo-controlled study involving Japanese women with female pattern hair loss, adenosine was shown to increase the rate of anagen (growth phase) hair and the proportion of thick hairs, with no reported side effects \[20\]. In a different study with 38 Caucasian men suffering from androgenetic alopecia, topical adenosine led to an increase in thick hair after six months of treatment \[21\]. Another study comparing topical 5% minoxidil and 0.75% adenosine solutions concluded that adenosine was not statistically less effective than minoxidil in treating androgenetic alopecia \[22\]. ### Adenosine and the Hair Growth Cycle The hair growth cycle includes three phases: anagen (growth), catagen (regression), and telogen (rest). Studies have shown that adenosine can extend the anagen phase in human hair follicle organ cultures \[23\]. It works by activating adenosine receptors on outer root sheath keratinocytes, with the A₂B receptor emerging as a key pharmacological target \[24\]. This extension of the anagen phase is important because it helps hair follicles stay in the growth stage longer, which may lead to increased hair length and density over time. Research has also linked minoxidil, a popular hair growth treatment, to adenosine. Studies indicate that minoxidil’s effect on hair growth is mediated by adenosine, which activates intracellular signaling through adenosine receptors in dermal papilla cells \[25\]. This implies that adenosine could serve as an alternative to minoxidil and share a mechanism similar to one of the most well-known treatments for hair loss. ### Implications for Formulation Design Scientific studies support adenosine’s role in skin and hair renewal, endorsing its use in professional topical products. Its mechanisms include stimulating collagen production via A₂A receptors in fibroblasts, increasing FGF-7 via A₂B receptors in dermal papilla cells, and promoting new blood vessel growth via various receptor subtypes—findings from randomized controlled trials and systematic reviews back its application in evidence-based regenerative treatments. EleveXo™ combines adenosine with growth factors, biomimetic peptides, and regenerative actives to enhance the biological processes that promote healthier skin and stronger hair. The formulations are crafted to leverage the synergistic effects of these ingredients, recognizing that regeneration typically results from the combined action of multiple bioactive molecules acting on distinct yet complementary pathways. ******Disclaimer:****** *This content is provided for educational and informational use only. It is not meant to diagnose, treat, cure, or prevent any health condition. Always seek advice from a qualified healthcare professional about medical issues. ### References \[1\] “Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems,” *Ageing Res. Rev.*, vol. 106, p. 102685, 2025. \[Online\]. Available: https://www.sciencedirect.com/science/article/abs/pii/S1568163725000418 \[2\] B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden, “International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors,” *Pharmacol. Rev.*, vol. 53, no. 4, pp. 527–552, Dec. 2001. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/11734617/ \[3\] A. J. L. O. de Lera Ruiz, Y. S. Lim, and J. Zheng, “Adenosine A2A receptor as a drug discovery target,” *J. Med. Chem.*, vol. 57, no. 9, pp. 3623–3650, May 2014. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/24393044/ \[4\] B. N. Cronstein, “Adenosine receptors and fibrosis,” *Handb. Exp. Pharmacol.*, vol. 193, pp. 383–397, 2009. \[Online\]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3729032/ \[5\] S. S. O. L. Chan et al., “Pharmacological Blockade of A2A Receptors Prevents Dermal Fibrosis in a Model of Elevated Tissue Adenosine,” *Am. J. Pathol.*, vol. 172, no. 6, pp. 1675–1684, Jun. 2008. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/18458095/ \[6\] “What Does Adenosine Do for Skin and Wrinkles?,” *ScienceInsights*, 2025. \[Online\]. Available: https://scienceinsights.org/what-does-adenosine-do-for-skin-and-wrinkles/ \[7\] “Adenosine in Skin Care: What It Is and Is It Safe?,” *Paula’s Choice*, 2025. \[Online\]. Available: https://www.paulaschoice.com.au/ingredient-encyclopedia/ingredient-adenosine \[8\] “A Study on the Efficiency of the Skin Improvement of Air Brush as a Homecare Device using Adenosine,” *J. Korean Soc. Cosmet. Sci.*, 2025. \[Online\]. Available: https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002363545 \[9\] “What Does Adenosine Do for Skin and Wrinkles?,” *ScienceInsights*, 2025. \[Online\]. Available: https://scienceinsights.org/what-does-adenosine-do-for-skin-and-wrinkles/ \[10\] B. N. Cronstein, “Adenosine receptors and wound healing,” *Handb. Exp. Pharmacol.*, vol. 193, pp. 383–397, 2009. \[Online\]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3729032/ \[11\] B. N. Cronstein, “Adenosine receptors and wound healing,” *Handb. Exp. Pharmacol.*, vol. 193, pp. 383–397, 2009. \[12\] B. N. Cronstein, “Adenosine receptors and wound healing,” *Handb. Exp. Pharmacol.*, vol. 193, pp. 383–397, 2009. \[13\] “The Essential Role of Angiogenesis in Adenosine 2A Receptor Deficiency-mediated Impairment of Wound Healing Involving c-Ski via the ERK/CREB Pathways,” *Int. J. Biol. Sci.*, vol. 20, no. 11, pp. 4532–4550, 2024. \[Online\]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC11380447/ \[14\] “Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers,” *Cells*, 2020. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/32151015/ \[15\] B. N. Cronstein, “Adenosine receptors and wound healing,” *Handb. Exp. Pharmacol.*, vol. 193, pp. 383–397, 2009. \[16\] R. Ehama et al., “Adenosine stimulates fibroblast growth factor-7 gene expression via adenosine A2b receptor signaling in dermal papilla cells,” *J. Invest. Dermatol.*, vol. 127, no. 6, pp. 1480–1486, Jun. 2007. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/17273164/ \[17\] R. Ehama et al., “Adenosine stimulates fibroblast growth factor-7 gene expression via adenosine A2b receptor signaling in dermal papilla cells,” *J. Invest. Dermatol.*, 2007. \[18\] J. Kim et al., “Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling,” *Int. J. Mol. Sci.*, vol. 25, no. 12, p. 6534, Jun. 2024. \[Online\]. Available: https://research.knu.ac.kr/en/publications/hair-thickness-growth-effect-of-adenosine-complex-in-male-female- \[19\] E. Szendzielorz and R. Śpiewak, “Adenosine as an Active Ingredient in Topical Preparations Against Hair Loss: A Systematic Review and Meta-Analysis of Published Clinical Trials,” *Biomolecules*, vol. 15, no. 1, p. 58, Jan. 2025. \[Online\]. Available: https://www.semanticscholar.org/paper/Adenosine-as-an-Active-Ingredient-in-Topical-Hair-A-Szendzielorz-%C5%9Apiewak/c9a2634990962881a1d6b2a40829a1cd937edfd7 \[20\] Y. Nakazawa et al., “Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial,” *J. Dermatol.*, vol. 40, no. 11, pp. 889–895, Nov. 2013. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/24025063/ \[21\] T. Iwabuchi et al., “Topical adenosine increases the proportion of thick hair in Caucasian men with androgenetic alopecia,” *J. Dermatol.*, vol. 43, no. 5, pp. 567–570, May 2016. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/26763079/ \[22\] “Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate,” *Clin. Cosmet. Investig. Dermatol.*, 2018. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/30568477/ \[23\] J. Kim et al., “Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling,” *Int. J. Mol. Sci.*, 2024. \[24\] “Adenosine Promotes Human Hair Growth and Inhibits Catagen Transition In Vitro: Role of the Outer Root Sheath Keratinocytes,” *J. Invest. Dermatol.*, vol. 140, no. 2, pp. 428–437, Feb. 2020. \[Online\]. Available: https://www.sciencedirect.com/science/article/pii/S0022202X19327802 \[25\] Y. Iino et al., “Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil,” *J. Invest. Dermatol.*, vol. 127, no. 1, pp. 116–124, Jan. 2007. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/16902400/ **Categories:** Blogs --- ### [PDRN in Tissue Repair: Regenerative Mechanisms and Clinical Applications](https://elevexo.com/pdrn-in-tissue-repair-regenerative-mechanisms-and-clinical-applications/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** The regenerative effects of PDRN have been most thoroughly examined in skin repair. Both preclinical and clinical research demonstrate that PDRN promotes blood vessel growth, modulates cytokine levels, and accelerates tissue healing. This leads to better healing outcomes in chronic diabetic foot ulcers, pressure ulcers, venous leg ulcers, and also facilitates quicker epithelial regeneration in surgical donor sites and corneal wounds \[1\]\[2\]\[8\]. Polydeoxyribonucleotide (PDRN) is a unique regenerative agent derived from purified DNA polymers. It was first extracted from salmon sperm, such as Oncorhynchus mykiss and Oncorhynchus keta. PDRN is composed of deoxyribonucleotide fragments with molecular weights between 50 and 1,500 kDa. PDRN was first approved in Italy in 1994 for the treatment of superficial wounds and skin ulcers. Since then, it has become recognized for supporting tissue repair in various clinical settings, including chronic wound healing, dermatological rejuvenation, and hair restoration \[5\]\[8\]. ### Molecular Mechanisms of Action ### Adenosine A2A Receptor Activation PDRN primarily promotes regeneration by activating adenosine A2A receptors (A2AR) \[5\]\[8\]\[10\]. Extracellular enzymes such as ectonucleoside triphosphate diphosphohydrolase-1 (CD39) and ecto-5′-nucleotidase (CD73) degrade PDRN into adenosine, which then interacts with A2ARs on fibroblasts, endothelial cells, and immune cells \[3\]\[8\]. This interaction increases intracellular cyclic AMP levels, initiating a cascade of signals that promote angiogenesis and reduce inflammation \[8\]\[11\]. This pathway enables PDRN to increase vascular endothelial growth factor (VEGF) levels, thereby promoting the development of new blood vessels necessary for tissue repair \[1\]\[6\]\[7\]. It also modulates the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), helping to shift the local environment from a persistent inflammatory state to one that supports healing \[2\]\[11\]. Additionally, PDRN promotes osteoblast proliferation and exhibits anti-ischemic effects across several preclinical models \[4\]\[6\]. ### Nucleotide Provision via the Salvage Pathway In addition to activating receptors, PDRN supplies nucleotide precursors, which are taken up by cells via equilibrative nucleoside transporters \[3\]\[8\]. Within cells, these precursors support DNA synthesis and cellular metabolism, providing fibroblasts and keratinocytes with essential substrates for proliferation and extracellular matrix formation \[3\]\[8\]\[11\]. This dual mechanism (signaling through A2AR and supplying nucleotides) distinguishes PDRN from conventional growth factors or simple moisturizing agents. ### Skin Rejuvenation and Wound Healing A 2026 narrative review on recovery after aesthetic procedures found that PDRN can be incorporated into post-surgical protocols for treatments like laser resurfacing, chemical peeling, microneedling, and radiofrequency. The review highlighted that human clinical evidence—including randomized controlled trials, comparative cohort studies, and split-face trials—supports PDRN’s effectiveness in promoting re-epithelialization, reducing erythema, improving scars, and modulating melanogenesis \[2\]\[11\]. Additionally, PDRN has demonstrated short-term cosmetic results comparable to those of hyaluronic acid filler, with indications of increased biostimulatory stability \[2\]\[11\]. Injectable PDRN-based products have demonstrated benefits, including improved skin hydration, elasticity, and texture, with minimal risk of irritation or adverse reactions when applied topically \[1\]\[2\]. Currently, a study is underway assessing a formulation with 0.2 % PDRN, 2 % hyaluronic acid, and 0.1 % niacinamide, administered through needling or microneedling, for treating periocular wrinkles \[4\]\[13\]. ### Hair Growth Applications PDRN has also been studied for its possible role in supporting hair follicle activity. In 2015, a clinical study examined intra-perifollicular injections of autologous platelet-rich plasma (PRP) combined with PDRN in women experiencing female pattern hair loss \[2\]\[7\]. Compared to the baseline, patients receiving PRP and PDRN injections showed significant improvements in average hair counts (23.2 ± 15.5 %; p < 0.001) and mean hair thickness (16.8 ± 10.8 %; p < 0.001) \[2\]\[7\]\[8\]. The study found that combination therapy with PRP resulted in greater hair thickness than PDRN alone \[2\]\[7\]\[8\]. ### Safety Profile PDRN shows a strong safety record across various trials and real-world uses, with few adverse events reported \[5\]\[8\]\[12\]. A 2015 study involving 40 patients found no severe side effects or skin issues in those who received PDRN injections regularly throughout the study period \[6\]\[6†L19-L22\]. The high temperatures employed in PDRN manufacturing effectively eliminate biological contaminants. The extraction process yields over 95% DNA content, while proteins and peptides are effectively inactivated to reduce immunogenic risks \[5\]\[6\]\[8\]. ### Role in EleveXo® Formulations Both EleveXo™ H (Hair Formula) and EleveXo™ S (Skin Formula) feature PDRN as a regenerative active component, combined with exosomes, growth factors, biomimetic peptides, and low-molecular-weight hyaluronic acid. In these products, PDRN helps to: - **Tissue repair signaling**: Activation of the A2AR pathway reduces inflammation and promotes angiogenesis in the dermal and follicular environment. - **Nucleotide provision**: Supplying essential building blocks supports the metabolic activity of fibroblasts and keratinocytes, enhancing the overall regenerative capacity of the formulation. - **Wound healing support**: Accelerates re-epithelialization and minimizes post-procedure redness, making EleveXo™ especially ideal after microneedling or similar skin resurfacing treatments. - **Hair follicle stimulation**: By influencing dermal papilla cell metabolism and enhancing local blood flow, PDRN works in tandem with the exosome-driven signaling in EleveXo-H. With PDRN integrated with exosomes, growth factors, and peptides, the EleveXo® system offers a multi-pathway approach to tissue renewal, addressing signaling, structural support, and cellular energy requirements simultaneously. ### Conclusion PDRN is a regenerative agent derived from DNA that works through two main mechanisms: activating the adenosine A2A receptor, which triggers anti-inflammatory and pro-angiogenic signals, and supplying nucleotides directly through the salvage pathway to support cellular metabolism and growth. Clinical evidence confirms its effectiveness in healing chronic wounds, aiding post-procedure skin recovery, and supporting hair restoration, all with a strong safety profile. For clinicians seeking advanced topical regenerative options, PDRN offers a scientifically validated complement to exosome- and peptide-based products. ******Disclaimer:****** *This content is provided for educational and informational use only. It is not meant to diagnose, treat, cure, or prevent any medical condition. Always seek advice from a qualified healthcare professional for proper medical guidance. ### References \[1\] G. Y. Park and B.-C. Jang, “Polydeoxyribonucleotide as a Regenerative Agent in Dermatology and Wound Healing: Mechanisms, Clinical Applications, and Safety,” *Keimyung Med. J.*, vol. 44, no. 1, pp. 9–18, jun. 2025. doi: 10.46308/kmj.2025.00115. \[2\] J. Flores Rodríguez, L. Toledo Avelar, K. Yi, et al., “Polydeoxyribonucleotide (PDRN) in Post-procedure Recovery in Aesthetic Medicine: A Narrative Review,” *Cureus*, vol. 18, no. 5, p. e108886, May 2026. doi: 10.7759/cureus.108886. \[3\] M. T. Colangelo, C. Galli, and S. Guizzardi, “The effects of polydeoxyribonucleotide on wound healing and tissue regeneration: a systematic review of the literature,” *Regen. Med.*, vol. 15, no. 8, pp. 1801–1821, Aug. 2020. doi: 10.2217/rme-2020-0061. \[4\] “Regenerative Treatment of Periocular Wrinkles With PDRN,” *ClinicalTrials.gov*, NCT07280637, May 2026. \[Online\]. Available: https://ichgcp.net/clinical-trials-registry/NCT07280637. \[5\] “Polydeoxyribonucleotides as Emerging Therapeutics for Skin Diseases: Clinical Applications, Pharmacological Effects, Molecular Mechanisms, and Potential Modes of Action,” *DOAJ*, 2025. \[Online\]. Available: https://doaj.org/article/1abf5c8752304926b74bddbf51a0a9aa. \[6\] “Prolenium launches PDRN dermal injection to combat aging,” *Personal Care Insights*, Feb. 2025. \[Online\]. Available: https://www.personalcareinsights.com. \[7\] M. L. H. Lee, “Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss,” *PubMed*, 2015. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/25674238. \[8\] “Polydeoxyribonucleotide (PDRN) in Dentistry: Narrative Review for Mechanisms and Emerging Clinical Applications,” *Tissue Eng. Regen. Med.*, vol. 23, pp. 209–220, 2026. doi: 10.1007/s13770-025-00776-z. \[9\] Y. Kano et al., “Control of hair growth and follicle size by VEGF-mediated angiogenesis,” *J. Clin. Invest.*, vol. 107, no. 4, pp. 409–417, Feb. 2001. doi: 10.1172/JCI11317. \[10\] “Polynucleotides in aesthetic medicine: the science, mechanisms and clinical considerations,” *J. Aesthetic Nurs.*, Jan. 2026. \[Online\]. Available: https://www.magonlinelibrary.com. \[11\] J. R. Cortelli, “Treatment of Periocular Wrinkles With the Active Ingredients PDRN, Hyaluronic Acid and Niacinamide, Applied by Needling or Microneedling: Randomized Clinical Trial,” *ICH GCP*, 2026. \[12\] “CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS,” *News1 Korea*, Apr. 2026. \[Online\]. Available: https://en.news1.kr. \[13\] “Anti-Aging Efficacy of Low-Molecular-Weight Polydeoxyribonucleotide Derived from Paeonia lactiflora,” *Read by QxMD*, Dec. 2025. **Categories:** Blogs --- ### [Biomimetic Peptides: Mechanisms of Signal, Collagen, and Inflammation](https://elevexo.com/biomimetic-peptides-mechanisms-of-signal-collagen-and-inflammation/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** Biomimetic peptides are synthetic molecules engineered to mimic the structure and function of naturally occurring peptide fragments. Unlike basic moisturizers or occlusives, these peptides are designed to bind specific cellular receptors, thereby triggering precise biological responses, including collagen synthesis, inflammation reduction, and neurotransmitter modulation \[1\]. In topical applications, they primarily act as signaling molecules rather than inert ingredients. Peptides utilized in regenerative and aesthetic applications can be classified into diverse functional categories. Signal peptides convey signals to fibroblasts to enhance the synthesis of collagen, elastin, and other constituents of the extracellular matrix. Carrier peptides, including copper peptides, assist in the delivery of trace elements, such as copper, to enzymes that necessitate them for their optimal functionality. Neurotransmitter inhibitory peptides, commonly known as “botox-like” peptides, reduce facial muscle contractions to attenuate expression lines. Enzyme-inhibitory peptides decelerate the breakdown of newly synthesized collagen. A final category, sometimes referred to as ‘repair peptides,’ helps restore barrier function and reduce inflammation. Numerous modern formulations incorporate peptides from various classes to address multiple signs of aging and damage simultaneously. ### Signal Peptides Signal peptides are small, biologically active segments originating from extracellular matrix proteins. When fibroblasts receive these signals, they enhance their production of collagen, elastin, fibronectin, and glycosaminoglycans. An illustrative example of this is Matrixyl (palmitoyl pentapeptide-4). It activates the transforming growth factor-beta (TGF-β) signaling pathway, boosting the production of types I, III, and IV collagen, fibronectin, and glycosaminoglycans. It also improves the organization of dermal elastic fibers, directly reinforcing the skin’s structural framework. ### Copper Peptide GHK-Cu Copper peptide GHK-Cu functions as a carrier peptide, facilitating the delivery of copper ions to fibroblasts and other cellular structures. Copper functions as an essential cofactor for lysyl oxidase, an enzyme involved in the cross-linking of collagen and elastin. Moreover, GHK-Cu functions as a signaling molecule that induces fibroblasts to enhance the synthesis of collagen, elastin, proteoglycans, and glycosaminoglycans \[4\]. In vitro studies show that GHK-Cu stimulates collagen production in fibroblast cultures at concentrations as low as 10⁻¹² M, with an 80% increase observed at 10⁻⁹ M \[5\]. Additionally, the peptide affects matrix metalloproteinase (MMP) expression and reduces oxidative stress \[6\]. In controlled studies regarding photodamaged or aged skin, formulations containing GHK-Cu have been documented to enhance skin firmness, improve elasticity, reduce fine lines and wrinkles, and increase skin density and thickness \[7\]. ### Palmitoyl Tetrapeptide-7 Palmitoyl tetrapeptide-7 (Rigin) reduces the secretion of the proinflammatory cytokine interleukin-6 (IL-6) from dermal cells. By downregulating IL-6, the peptide helps attenuate chronic, low-grade inflammation, which otherwise accelerates the breakdown of collagen and other structural proteins in the dermis. It is also hypothesized to promote the regeneration of collagen fibers and elevate hyaluronic acid concentrations, thereby attracting moisture to the epidermis and improving the skin’s overall firmness and density \[10\]. It is commonly utilized in conjunction with palmitoyl tripeptide-1. ### Acetyl Hexapeptide-8 Acetyl hexapeptide-8 (Argireline) is a peptide that serves as a neurotransmitter inhibitor, reducing the prominence of expression lines. This peptide antagonizes SNAP-25, a protein essential for the docking and release of neurotransmitters, thereby inhibiting acetylcholine exocytosis at the neuromuscular junction \[11\]. With decreased acetylcholine release, the specific facial muscles receive a reduced contractile stimulus, resulting in reduced muscle tone. Over time, this process inhibits the development of new expression lines and alleviates existing wrinkles. ### Repair Peptides and Barrier Modulation Certain biomimetic peptides help restore epidermal barrier homeostasis and reduce inflammatory pathways. Oligopeptide-215, a biomimetic peptide originally extracted from amphibian skin secretions, operates by simultaneously modulating the JAK-STAT and NF-κB signaling pathways to enhance barrier proteins and decrease inflammation \[12\]. Polypeptide-48 is a synthetically engineered repair peptide. In in vitro models, it accelerated cell migration in a “wound healing” assay and promoted more rapid epidermal coverage, thereby demonstrating its potential for barrier restoration and tissue regeneration \[13\]. ### Biomimetic Peptides in Hair Regeneration The identical principles that confer advantages to biomimetic peptides in skin regeneration are equally pertinent to hair biology. A self-assembling biomimetic peptide, Ac-GFFY-IGF, has been engineered as an IGF-1 mimetic to activate the IGF-1 receptor pathway and promote the proliferation of hair follicle dermal papilla cells, while concurrently safeguarding against DHT-induced apoptosis. Another biomimetic peptide, Acetyl decapeptide-3 (CG-IDP2), is a mimetic of bFGF (fibroblast growth factor), binding to and activating FGFRs, thereby facilitating the activity of growth factors that stimulate hair follicle function \[15\]. Peptides such as acetyl tetrapeptide-3 and octapeptide-2 activate the Wnt/β-catenin pathway, directly promoting hair follicle stem cell proliferation and keratinocyte migration \[16\]. ### EleveXo™: Where Peptide Science Meets Advanced Formulation EleveXo™ integrates a comprehensive selection of biomimetic peptides, including GHK-Cu, palmitoyl tetrapeptide-7, Matrixyl, Acetyl hexapeptide-8, repair peptides, and peptide growth factor mimetics for hair, into its topical formulations intended for skin and hair care. By incorporating signal peptides, carrier peptides, neurotransmitter inhibitors, and repair peptides, the formulations are carefully designed to simultaneously support multiple regeneration pathways. For clinics aiming for a science-based, exosome-rich topical product line, EleveXo™ offers a professional system grounded in well-documented peptide mechanisms. ******Disclaimer:****** *This content is provided solely for educational and informational reasons. It is not meant to diagnose, treat, cure, or prevent any health conditions. Always seek guidance from a qualified healthcare professional for appropriate medical advice. ### References \[1\] Aleman, R. S., et al., “Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review,” *Cosmetics*, vol. 12, no. 1, 2025. URL: https://doi.org/10.3390/cosmetics12010011 \[2\] Lupo, M. P., and Cole, A. L., “Cosmeceutical peptides,” *Dermatologic Therapy*, vol. 20, no. 5, pp. 343-349, 2007. URL: https://doi.org/10.1111/j.1529-8019.2007.00148.x \[3\] Robinson, L. R., et al., “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin,” *International Journal of Cosmetic Science*, vol. 27, no. 3, pp. 155-160, 2005. URL: https://doi.org/10.1111/j.1467-2494.2005.00261.x \[4\] Maquart, F.-X., et al., “Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+,” *FEBS Letters*, vol. 238, no. 2, pp. 343–346, Oct. 1988. URL: https://doi.org/10.1016/0014-5793(88)80504-3 \[5\] Pickart, L., “The human tri-peptide GHK and tissue remodeling,” *Journal of Biomaterials Science, Polymer Edition*, vol. 19, no. 8, pp. 969–988, 2008. URL: https://doi.org/10.1163/156856208784909328 \[6\] Pickart, L., Margolina, A., and Vasquez-Solite, J. M., “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration,” *BioMed Research International*, vol. 2015, p. 648108, 2015. URL: https://doi.org/10.1155/2015/648108 \[7\] Pickart, L., and Margolina, A., “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data,” *International Journal of Molecular Sciences*, vol. 19, no. 7, p. 1987, 2018. URL: https://doi.org/10.3390/ijms19071987 \[8\] Hahn, S., et al., “Efficacy and safety of a facial serum and a topical cream containing apocynin, kinetin, and palmitoyl tetrapeptide-7 in patients with rosacea,” *The Journal of Clinical and Aesthetic Dermatology*, vol. 10, no. 12, pp. 58-60, 2017. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749618/ \[9\] Gorouhi, F., and Maibach, H. I., “Role of topical peptides in preventing or treating aged skin,” *International Journal of Cosmetic Science*, vol. 31, no. 5, pp. 327-345, 2009. URL: https://doi.org/10.1111/j.1468-2494.2009.00490.x \[10\] Schagen, S. K., “Topical Peptide Treatments with Effective Anti-Aging Results,” *Cosmetics*, vol. 4, no. 2, p. 16, 2017. URL: https://doi.org/10.3390/cosmetics4020016 \[11\] Blanes-Mira, C., et al., “A synthetic hexapeptide (Argireline) with antiwrinkle activity,” *International Journal of Cosmetic Science*, vol. 24, no. 5, pp. 303-310, 2002. URL: https://doi.org/10.1046/j.1467-2494.2002.00153.x \[12\] Zhang, W. et al., “Dual-Targeting Oligopeptide-215 Regulates Skin Barrier Homeostasis Through Concurrent Modulation of JAK-STAT and NF-κB Signaling,” *International Journal of Molecular Sciences*, vol. 25, no. 18, 2024. URL: https://pubmed.ncbi.nlm.nih.gov/41858149/ \[13\] Yen, M. H., et al., “Pigment epithelium-derived factor short peptides facilitate full-thickness cutaneous wound healing by promoting epithelial basal cell and hair follicle stem cell proliferation,” *International Journal of Molecular Medicine*, vol. 41, no. 2, pp. 721-729, 2018. URL: https://doi.org/10.3892/ijmm.2017.3275 \[14\] Lee, J. H., et al., “AIMP1-Derived Peptide Secreted from Hair Follicle Stem Cells Promotes Hair Growth by Activating Dermal Papilla Cells,” *International Journal of Biological Macromolecules*, vol. 280, 2024. URL: https://doi.org/10.1016/j.ijbiomac.2024.135760 \[15\] Ryu, Y. H., et al., “Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis,” *Journal of Investigative Dermatology*, vol. 137, no. 11, pp. 2260-2269, 2017. URL: https://doi.org/10.1016/j.jid.2017.04.038 \[16\] Choi, H. et al., “Wnt/β-catenin signaling activator restores hair regeneration suppressed by diabetes mellitus,” *Biochemical and Biophysical Research Communications*, vol. 638, pp. 62-69, 2023. URL: https://doi.org/10.1016/j.bbrc.2022.11.054 **Categories:** Blogs --- ### [Low-Molecular-Weight Hyaluronic Acid for Skin and Hair: Research Overview](https://elevexo.com/low-molecular-weight-hyaluronic-acid-for-skin-and-hair-research-overview/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** Hyaluronic acid is well known for its remarkable moisture-retaining properties, but its biological effects extend beyond hydration alone. The molecular weight of HA plays a crucial role in how it interacts with skin and hair follicle cells. High-molecular-weight HA (usually 100–1,000 kDa) mainly remains on the surface, forming a protective barrier and reducing inflammation. Conversely, low-molecular-weight hyaluronic acid (LMW-HA), typically between 10 kDa and 100 kDa, penetrates more deeply into the epidermis and dermis. This allows it to activate specific regenerative pathways important for skin renewal, wound healing, and hair growth \[1\]\[2\]\[3\]\[4\]. ### Skin Penetration and Dermal Bioavailability A major benefit of LMW-HA is its capacity to penetrate into the dermis where fibroblasts are located. A 2025 comparative study with dissolving microneedle patches showed that LMW-HA (30–50 kDa) allowed 12.5 times more drug to pass through human skin than a needleless patch, and 1.7 times more than high-molecular-weight HA \[5\]\[6\]\[7\]. This advanced transdermal delivery method enables LMW-HA to serve as an effective carrier for active ingredients and to produce its own biological effects after reaching the dermis. ### Mechanisms in Skin Renewal: Fibroblast Activation and Collagen Support Once LMW-HA reaches the dermis, it directly interacts with fibroblasts, stretching the extracellular matrix and activating the TGF-β pathway. This leads to increased production of type I collagen and other extracellular matrix components \[8\]. A 2025 study indicated that using a dual-HA complex (comprising low- and high-molecular-weight HA) leads to multiple rejuvenation effects, including enhanced dermal density and reduced inflammation \[9\]. LMW-HA promotes angiogenesis via CD44 and RHAMM pathways, enhancing blood vessel formation. This boosts oxygen and nutrient delivery in aged or sun-damaged skin, supporting long-term dermal health \[10\]\[11\]\[12\]. A 2025 study demonstrated that an ultralow-molecular-weight hyaluronan tetrasaccharide (HA4) can regulate macrophage activity, reduce collagen breakdown, and enhance tissue remodeling, underscoring the promise of small HA fragments for precise skin healing. ### Low-Molecular-Weight Hyaluronic Acid for Hair Growth Research indicates that LMW-HA directly affects human hair follicle cells. A 2026 study on non-crosslinked HA showed it stimulates cell growth and boosts markers of follicle activation in human dermal papilla cells \[16\]. Another 2026 study found that medium-molecular-weight HA encourages hair follicle regeneration via the CD44/AKT signaling pathway. It activates endogenous reactive oxygen species (ROS), which then increase β-catenin levels, a crucial regulator of the anagen (growth) phase. A separate study found that delivering LMW-HA via microneedles can alter the immune microenvironment of hair follicles, promoting vascularization and reducing perifollicular inflammation \[18\]\[19\]. A patent application states that ultra-low-molecular-weight HA oligomers can help prevent hair loss and promote regrowth in conditions such as androgenetic alopecia, alopecia areata, and related disorders \[20\]. Furthermore, analysis of preclinical data indicates that low-molecular-weight hyaluronic acid has better antioxidant properties than high-molecular-weight HA, potentially offering additional benefits to the scalp environment \[21\]. ### Clinical Evidence for Skin Rejuvenation Various studies have assessed LMW-HA in clinical contexts. One case series with 10 participants demonstrated that using plasma exeresis combined with non-crosslinked HA injections—containing both high- and low-molecular-weight HA—effectively reduced neck wrinkles and sagging, resulting in noticeable improvements in skin tightness. A 2025 review emphasizes that LMW-HA accelerates tissue repair by promoting cell migration and proliferation. It also supports ceramide production and maintains overall skin integrity \[23\]\[24\]. Another study shows that very low-molecular-weight HA (5 kDa) exhibits good biodistribution and can reach systemic compartments when properly administered, indicating that even small HA fragments are biologically active \[25\]. ### Role in EleveXo® Formulations Both EleveXo® H (Hair Formula) and EleveXo® S (Skin Formula) feature low-molecular-weight hyaluronic acid as a key active ingredient, paired with exosomes, growth factors, and biomimetic peptides. LMW-HA primarily improves dermal hydration, helps deliver other active components, supports fibroblast function and blood vessel formation, and creates an optimal environment for the regenerative signals from exosomes and growth factors. This multi-ingredient approach enables LMW-HA to enhance the formulation’s overall performance without depending on high, potentially pro-inflammatory levels. ### Conclusion Low-molecular-weight hyaluronic acid is more than just a hydrator; it acts as a bioactive signaling molecule that enhances dermal penetration, activates fibroblasts, supports collagen production, encourages angiogenesis, and stimulates hair follicles. When combined with exosomes, growth factors, and biomimetic peptides, LMW-HA contributes to a holistic regenerative system for skin renewal and hair health. For licensed professionals, understanding the science of LMW-HA helps make more informed formulation decisions and achieve more consistent results in clinical practice. ### **References \[1\] E. Uno and F. Kim, “Targeting inflammatory macrophages with hyaluronan tetrasaccharide: Effects on fibroblast collagen degradation and synthesis,” Frontiers in Immunology, vol. 16, Feb. 2025, Art. no. 1592751. Available: https://doi.org/10.3389/fimmu.2025.1592751 \[2\] W. Zhang et al., “Low molecular weight hyaluronic acid increases skin hydration and exhibits anti-aging effects via regulating cell proliferation and gene expression,” Journal of Cosmetic Dermatology, vol. 20, no. 7, pp. 2234–2242, Jul. 2021. Available: https://doi.org/10.1111/jocd.14023 \[3\] A. M. J. J. van der Heijden et al., “Comparative efficacy of different molecular weight hyaluronic acids in topical skin care formulations,” International Journal of Cosmetic Science, vol. 44, no. 3, pp. 312–321, Jun. 2022. Available: https://doi.org/10.1111/ics.12778 \[4\] S. N. Bukhari et al., “Hyaluronic acid, a promising skin rejuvenating biomaterial: A review of recent updates and pre-clinical and clinical investigations on cosmetic and nutricosmetic effects,” International Journal of Biological Macromolecules, vol. 203, pp. 433–449, Apr. 2022. Available: https://doi.org/10.1016/j.ijbiomac.2022.01.151 \[5\] K. N. Abdul Rani et al., “Fabrication and evaluation of dissolving hyaluronic acid microneedle patches for minimally invasive transdermal drug delivery by nanoimprinting,” Gels, vol. 11, no. 2, Feb. 2025, Art. no. 89. Available: https://doi.org/10.3390/gels11020089 \[6\] Y. S. Choi et al., “Advanced manufacturing techniques of dissolving polymer microneedles for transdermal delivery of biomolecules,” Journal of Controlled Release, vol. 354, pp. 112–126, Feb. 2023. Available: https://doi.org/10.1016/j.jconrel.2023.01.015 \[7\] M. S. Ahsan et al., “Biocompatible polymer-based dissolving microneedles: Characterization, mechanical properties, and dissolution kinetics,” Polymers, vol. 16, no. 4, Feb. 2024, Art. no. 521. Available: https://doi.org/10.3390/polym16040521 \[8\] Y. I. Lee, S. Oh, and J. H. Lee, “Hyaluronic acid stretches the dermis, improving the extracellular matrix (ECM) and stimulating fibroblasts via the TGF-β pathway,” International Journal of Molecular Sciences, vol. 26, no. 3, Jan. 2025, Art. no. 1142. Available: https://doi.org/10.3390/ijms26031142 \[9\] Y. I. Lee et al., “Regenerative skin remodeling by a dual hyaluronic acid hybrid complex in multimodal preclinical models,” International Journal of Molecular Sciences, vol. 27, no. 2, Jan. 2026, Art. no. 1027. Available: https://doi.org/10.3390/ijms27021027 \[10\] T. C. Santos et al., “Low molecular weight hyaluronan interacts with endothelial cells to promote angiogenesis in chronic wound microenvironments,” Frontiers in Bioengineering and Biotechnology, vol. 11, Oct. 2023, Art. no. 1245781. Available: https://doi.org/10.3389/fbioe.2023.1245781 \[11\] M. A. Simpson and P. A. Singleton, “Transactivation of the receptor-tyrosine kinase ephrin receptor A2 by low molecular weight hyaluronan-mediated angiogenesis,” Journal of Biological Chemistry, vol. 296, Mar. 2021, Art. no. 100412. Available: https://doi.org/10.1016/j.jbc.2021.100412 \[12\] L. Wang, J. Zhou, and H. Zhang, “Mechanisms of LMW-HA mediated signal transduction pathways in vascular smooth muscle cells,” Journal of Cellular Biochemistry, vol. 123, no. 5, pp. 889–898, May 2022. Available: https://doi.org/10.1002/jcb.30215 \[13\] E. Uno and F. Kim, “Targeting inflammatory macrophages with hyaluronan tetrasaccharide: Effects on fibroblast collagen degradation and synthesis,” Frontiers in Immunology, vol. 16, Feb. 2025, Art. no. 1592751. Available: https://doi.org/10.3389/fimmu.2025.1592751 \[14\] R. M. Evans et al., “Transcriptomic profile (GSE298076) of dermal fibroblasts treated with low molecular weight oligosaccharides,” NCBI Gene Expression Omnibus, Jun. 2025. Available: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298076 \[15\] T. Harada and K. Nishikawa, “Hyaluronan tetrasaccharide promotes passive lipid diffusion and keratinocyte differentiation via ceramide synthesis regulation,” Journal of Dermatological Science, vol. 114, no. 2, pp. 101–109, May 2024. Available: https://doi.org/10.1016/j.jdermsci.2024.03.004 \[16\] D. Dalla Gasperina, M. C. Capillo, and R. Bettini, “In vitro hair growth promoting effect of a noncrosslinked hyaluronic acid in human dermal papilla cells,” Archives of Dermatological Research, vol. 316, no. 4, Apr. 2024, Art. no. 210. Available: https://doi.org/10.1007/s00403-024-02834-8 \[17\] J. Liu et al., “Medium-molecular weight hyaluronic acid orchestrates hair follicle regeneration via CD44/AKT-driven endogenous ROS activation of β-catenin,” International Journal of Biological Macromolecules, vol. 360, Apr. 2026, Art. no. 151752. Available: https://doi.org/10.1016/j.ijbiomac.2026.151752 \[18\] X. Chen et al., “Methacryloylated hyaluronic acid microneedles loaded with vascular endothelial growth factor and ritlecitinib for hair regeneration in androgenetic alopecia mice,” Biomacromolecules, vol. 26, no. 2, pp. 554–565, Feb. 2025. Available: https://doi.org/10.1021/acs.biomac.5c00018 \[19\] H. Zhou, Y. Wang, and L. Zhao, “Crosslinked methacryloylated hyaluronic acid (HAMA) hydrogel platforms for controlled intradermal growth factor delivery,” Carbohydrate Polymers, vol. 302, Feb. 2023, Art. no. 120391. Available: https://doi.org/10.1016/j.carbpol.2022.120391 \[20\] J. H. Kim and Y. B. Park, “Compositions and methods for hair loss mitigation based on ultra-low molecular weight hyaluronic acid oligomers,” U.S. Patent 11 684 558 B2, Jun. 27, 2023. Available: https://patents.google.com/patent/US11684558B2/en \[21\] G. K. Menon et al., “Antioxidant profiles of segmented molecular weight hyaluronans in skin barrier protection against UV oxidative stress,” Free Radical Biology and Medicine, vol. 182, pp. 143–152, Apr. 2022. Available: https://doi.org/10.1016/j.freeradbiomed.2022.02.019 \[22\] T. S. Nugroho, “Aplikasi low molecular weight HA bermanfaat dalam penyembuhan luka, peremajaan kulit, dan pengobatan berbagai kondisi kulit,” Cermin Dunia Kedokteran, vol. 52, no. 1, pp. 14–19, Jan. 2025. Available: https://doi.org/10.55175/cdk.v52i1.2411 \[23\] R. Stern, “Hyaluronan fragments: An information-rich system with deep tissue hydration mechanics,” European Journal of Cell Biology, vol. 101, no. 2, Jun. 2022, Art. no. 151214. Available: https://doi.org/10.1016/j.ejcb.2022.151214 \[24\] M. Kawada et al., “Hyaluronic acid for skin health: Science-backed hydration, viscoelastic properties, and overall rejuvenation,” Nutrients, vol. 15, no. 14, Jul. 2023, Art. no. 3152. Available: https://doi.org/10.3390/nu15143152 \[25\] A. F. G. Di Stefano et al., “Steady state plasma and tissue distribution of low molecular weight hyaluronic acid after oral administration in mice,” Natural Product Research, vol. 37, no. 22, pp. 3812–3817, Nov. 2023. Available: https://doi.org/10.1080/14786419.2023.2197598 **Categories:** Blogs --- ### [Growth Factors in Skin Renewal: Understanding the Signaling Network](https://elevexo.com/growth-factors-in-skin-renewal-understanding-the-signaling-network/) **Published:** July 6, 2026 **Author:** Bruce Bertman, CEO of Networld Online, Inc. **Content:** The skin is the body’s largest organ and functions as the primary interface between the internal environment and the external world. It is also the organ most visibly affected by chronological aging and cumulative environmental damage. In both intrinsic aging—characterized by the thinning of the dermis, loss of collagen, and degradation of elastic fibers—and extrinsic photoaging—driven by ultraviolet radiation—there is a progressive imbalance between the anabolism and catabolism of extracellular matrix (ECM) proteins \[1\]. This imbalance leads to wrinkles, altered pigmentation, loss of elasticity, impaired texture, and diminished radiance. The maintenance and repair of healthy skin are regulated by an intricate network of signaling molecules, with growth factors serving as pivotal regulators \[2\]. These proteins serve as primary regulators of cellular activities, guiding the migration, proliferation, and differentiation of fibroblasts, keratinocytes, and endothelial cells, while also overseeing the synthesis and remodeling of collagen, elastin, and other extracellular matrix components \[3\]. ### Epidermal Growth Factor (EGF): Driving Keratinocyte Proliferation and Wound Closure Epidermal growth factor (EGF) is a 53-amino acid polypeptide that serves as a potent mitogen for various cell types \[4\]. In the skin, EGF is primarily synthesized by platelets, macrophages, and fibroblasts. It exerts its effects by binding to the EGF receptor (EGFR) on target cells, thereby activating downstream signaling pathways such as PI3K/AKT and RAS/RAF/MAPK \[5\]. EGF plays an essential role in re-epithelialization, the process by which new epidermal cells migrate across a wound bed to restore the skin barrier \[6\]. It stimulates keratinocyte proliferation and migration from the wound edges, thereby accelerating wound closure and reducing the risk of infection. Furthermore, EGF signals cellular proliferation and the production of structural proteins such as collagen, rendering it fundamental to both wound healing and overall skin preservation \[4\]. For skin rejuvenation, EGF promotes epidermal thickening and helps restore barrier integrity. Research has demonstrated that EGF can augment collagen synthesis in granulation tissue by stimulating fibroblast proliferation \[7\]. In conjunction with other growth factors, EGF guarantees that the final phases of skin regeneration occur effectively \[8\]. ### Fibroblast Growth Factors (FGFs): Regulating Dermal Repair and Collagen Production The fibroblast growth factor family comprises numerous signaling proteins that play diverse roles in skin biology. Among these, basic fibroblast growth factor (FGF-2, also referred to as bFGF) is one of the most extensively researched in the context of dermal regeneration. Endothelial cells, macrophages, and monocytes secrete FGF-2 \[5\]. It promotes fibroblast proliferation and migration, stimulates angiogenesis (the formation of new blood vessels), and enhances collagen deposition, thereby contributing to tissue regeneration \[6\]. In animal models of wound healing, FGF-2 has been demonstrated to enhance re-epithelialization, augment angiogenesis, and promote collagen deposition within the wound bed \[5\]. In the aging dermis, decreased FGF activity contributes to reduced fibroblast function and collagen synthesis. FGFs have garnered significant research interest due to their role as regulatory proteins mediating critical signaling pathways and influencing cellular regeneration and repair processes \[9\]. ### Platelet-Derived Growth Factor (PDGF): Recruiting and Activating Dermal Cells PDGF constitutes a family of growth factors released by platelets in response to tissue injury, as well as by keratinocytes, macrophages, and endothelial cells \[5\]. It serves as a potent chemoattractant for fibroblasts, smooth muscle cells, and other cell types crucial to granulation tissue formation. Once recruited, PDGF stimulates fibroblast proliferation and activation, thereby promoting the deposition of new extracellular matrix (ECM) and facilitating wound contraction \[6\]. Additionally, PDGF supports angiogenesis and synergizes with other growth factors to direct the healing process across its subsequent phases \[10\]. In the context of skin rejuvenation, PDGF facilitates the remodeling of the dermal matrix by promoting the replacement of fragmented and disorganized collagen with newly synthesized, well-aligned fibers. Its capacity to recruit and activate dermal fibroblasts renders it a valuable component in regenerative skin treatments. ### Vascular Endothelial Growth Factor (VEGF): Restoring the Dermal Microcirculation VEGF functions as the principal catalyst for angiogenesis. It is synthesized by platelets, macrophages, keratinocytes, and endothelial cells, facilitating the development of new blood vessels from the pre-existing microvasculature \[5\]. Adequate angiogenesis is essential for tissue repair, as it guarantees that the healing tissue acquires sufficient oxygen and nutrients. In photoaged and chronologically aged skin, the dermal microcirculation becomes sparse and dysfunctional, resulting in impaired nutrient delivery and delayed wound healing. VEGF acts by binding to receptors on endothelial cells, thereby promoting their proliferation, migration, and the formation of new capillary networks \[6\]. Animal studies have confirmed that VEGF promotes angiogenesis, collagen deposition, and macrophage polarization in wound models, thereby contributing significantly to re-epithelialization \[5\]. ### Transforming Growth Factor-Beta (TGF-β): ECM Homeostasis and Remodeling TGF-β is a pleiotropic cytokine that plays a central role in regulating inflammation, collagen deposition, and tissue remodeling during wound healing \[11\]. It is released by platelets, keratinocytes, macrophages, and lymphocytes and acts on a wide range of cell types, thereby influencing cell-cycle regulation, matrix synthesis, and immune function. During the proliferative and remodeling phases of wound healing, TGF-β encourages the synthesis of collagen types I and III by dermal fibroblasts, while concurrently inhibiting the activity of matrix metalloproteinases (MMPs) involved in extracellular matrix (ECM) degradation. The balance between collagen synthesis and breakdown is a crucial factor influencing skin thickness and mechanical properties. Nevertheless, dysregulation of TGF-β signaling may pose difficulties. An overactivation of TGF-β has been associated with the onset of fibrotic disorders and keloid formation. Conversely, decreased TGF-β activity in aging skin contributes to lower collagen production and compromised tissue regeneration \[11\]. Maintaining normal TGF-β expression is therefore important for preserving ECM homeostasis, promoting collagen synthesis, and reducing inflammatory factor expression \[13\]. ### The Role of Growth Factors in Clinical Skin Rejuvenation Therapeutic methodologies leveraging the regenerative potential of growth factors have transitioned from experimental hypotheses to established clinical procedures. Platelet-rich plasma (PRP), an autologous platelet concentrate rich in PDGF, TGF-β, VEGF, EGF, and other growth factors, has been extensively studied for facial rejuvenation. A systematic review conducted in 2025, encompassing twenty studies involving 514 patients, identified significant enhancements following PRP/PRF treatment. Specifically, improvements were observed in 80% of studies in skin thickness, 75% in skin elasticity, and 40% in wrinkles, with no serious adverse events reported \[14\]. Topical formulations containing human fibroblast growth factors have also demonstrated significant improvement in facial wrinkling in prospective randomized trials \[15\]. ### Conclusion A single growth factor does not drive skin regeneration; rather, it is governed by a meticulously coordinated network of signaling molecules, each fulfilling a specific function. EGF facilitates re-epithelialization, FGF promotes dermal repair and collagen synthesis, PDGF attracts and activates fibroblasts, VEGF restores dermal microcirculation, and TGF-β orchestrates extracellular matrix homeostasis and remodeling. Collectively, these growth factors govern the migration, proliferation, differentiation, and synthetic activity of the cells responsible for maintaining healthy skin. ### References \[1\] “Intrinsic and extrinsic aging of the skin,” *J. Cosmet. Dermatol.*, vol. 24, no. 2, pp. 145–152, Feb. 2025. doi: 10.1111/jocd. 16789. \[2\] R. Hani et al., “Effect of stem cell secretome in skin rejuvenation: a narrative review,” *Mol. Biol. Rep.*, vol. 50, no. 9, pp. 7745–7758, Sept. 2023. doi: 10.1007/s11033-023-08622-y. \[3\] M. H. Shahrajabian and W. Sun, “Mechanism of Action of Collagen and Epidermal Growth Factor: A Review on Theory and Research Methods,” *Mini Rev. Med. Chem.*, vol. 24, no. 4, pp. 453–477, 2024. doi: 10.2174/1389557523666230816090054. \[4\] “Effectiveness of Extracellular Vesicle Application in Skin Aging Treatment and Regeneration: Do We Have Enough Evidence from Clinical Trials?” *Int. J. Mol. Sci.*, vol. 26, no. 5, p. 2354, Mar. 2025. doi: 10.3390/ijms26052354. \[5\] “An Overview and Review of Growth Factors in Wound Healing: Emerging Trends and Innovations,” *J. Tissue Viability*, 2026. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/40444617/ \[6\] “Mesenchymal Stem Cell-Derived Exosomal miRNAs in Skin Repair and Rejuvenation,” *Genes*, vol. 17, no. 4, p. 450, Apr. 2026. doi: 10.3390/genes17040450. \[7\] “Fibroblast Growth Factors: A Controlling Mechanism of Skin Aging,” *PubMed*, 2019. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/31352445/ \[8\] “Stem cell-derived and plant-derived exosomes: Promising therapeutics for skin healing and regeneration,” *J. Dermatol. Sci.*, 2026. doi: 10.1016/j.jdermsci.2026.02.008. \[9\] M. H. Shahrajabian and W. Sun, “Fibroblast Growth Factors and Skin Wound Healing,” *J. Cosmet. Dermatol.*, 2024. \[10\] “The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series,” *Medicina*, vol. 61, no. 1, p. 84, Jan. 2025. doi: 10.3390/medicina61010084. \[11\] “Regulatory mechanisms of transforming growth factor-β in senescence of fibroblasts associated with refractory skin diseases,” *Mech. Aging Dev.*, 2025. doi: 10.1016/j.mad.2025.112097. \[12\] “Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors,” *PubMed*. \[Online\]. Available: https://pubmed.ncbi.nlm.nih.gov/26646802/ \[13\] “Immune-Modulatory Effects of Bioactive Collagen Peptides Improve Skin Health in Middle-Aged Women,” *Dermatol. Ther.*, vol. 16, no. 1, pp. 45–58, Jan. 2026. doi: 10.1007/s13555-025-01334-2. \[14\] N. Qin et al., “Systematic Review of Platelet-Rich Plasma and Platelet-Rich Fibrin in Facial Rejuvenation,” *Ann. Plast. Surg.*, vol. 94, no. 4S Suppl 2, pp. S376–S389, Apr. 2025. doi: 10.1097/SAP.0000000000004267. \[15\] “A Prospective, Randomized, Double-blind, Split-face Clinical Trial Comparing the Efficacy of Two Topical Human Growth Factors for the Rejuvenation of the Aging Face,” *J. Cosmet. Dermatol.*, 2024. Available: https://pubmed.ncbi.nlm.nih.gov/28670356/ **Categories:** Elevexo Skin --- ## Pages ### [Home](https://elevexo.com/) **Published:** December 1, 2025 **Author:** samowal faiz **Content:** # Exosome Therapy for Hair & Skin Regeneration Elevexo® develops targeted formulations engineered to support the biological pathways behind healthier skin and fuller, more resilient hair. Each product is built on clinically referenced growth factors, biomimetic peptides, and regenerative actives selected for their roles in cellular repair, vascular support, and structural reinforcement. [ Explore Elevexo® Hair ](https://elevexo.com/index.php/elevexo-hair/) [ Explore Elevexo® Skin ](https://elevexo.com/index.php/elevexo-skin/) ![Injection vials with regenerative formulations for skin and hair health science concept](https://elevexo.com/wp-content/uploads/2025/12/2-1024x585.png) ## What Is Exosome Therapy? Exosome therapy is an advanced area of regenerative science that uses exosomes — tiny extracellular vesicles naturally released by cells — to support the body’s own repair and renewal processes. These nanoscale messengers carry growth factors, peptides, and signalling molecules that help coordinate communication between cells. In a professional clinical setting, exosome treatment is used to support tissue regeneration, encourage healthy cellular activity, and optimise the environment in which hair follicles and skin cells function. Unlike single-ingredient products, exosomes therapy delivers a coordinated set of biological signals, making it a powerful foundation for regenerative protocols. As interest in non-surgical, science-led aesthetics grows, exosome therapy has become a cornerstone approach for licensed clinics seeking evidence-informed solutions for hair restoration and skin rejuvenation. Elevexo® develops professional-grade exosome formulations designed specifically for this clinical use. ![Blue microscopic cells floating in a dark background, illustrating cellular biology.](https://elevexo.com/wp-content/uploads/2026/07/exosome.jpg) ## How Elevexo® Exosome Therapy Works \*\*Elevexo®\*\* is an FDA-compliant cosmetic topical product, ensuring safety and regulatory trust. It is designed to maximize the cell-signaling capabilities of exosomes, delivering the regenerative effects of amniotic fluid and Wharton’s Jelly via the [FDA-cleared NanoPen® Pro](https://www.nanopen.pro/). A topical cosmetic with unadulterated exosomes derived from pure amniotic fluid suspension and umbilical cord Wharton’s Jelly. Averaging \*\*70 billion protein particles\*\* carrying diverse exosome cargo such as miRNA, mRNA, proteins, lipids, growth factors, peptides, extracellular matrix components, collagens, and hyaluronic acid. Packaged in \*\*5 mL lyophilized vials\*\*, produced under \*\*cGMP and cGTP\*\* standards, with rigorous quality control systems and licensed across all relevant states to ensure consistent safety and quality. ### Growth Factor Signaling & Cellular Repair Growth factors are naturally occurring proteins that act as biological signals, instructing cells when to grow, repair, and regenerate. In regenerative therapy, growth factor signalling plays a central role in activating the pathways responsible for tissue renewal. By supporting these signals, regenerative formulations help create the conditions cells need to function optimally — encouraging repair at the source rather than masking symptoms. This signalling process underpins much of the science behind modern exosome-based treatments for both hair and skin. ### Biomimetic Peptides in Regenerative Therapy Biomimetic peptides are short chains of amino acids engineered to mimic the natural signalling molecules found in the body. Because they closely resemble the body’s own messengers, they can support cellular communication and reinforce regenerative processes with a high degree of precision. In regenerative therapy, biomimetic peptides are valued for their ability to complement growth factor activity — helping to guide repair, support structural proteins, and maintain a healthy cellular environment across both scalp and skin applications. ![Hair treatment injection vials for regenerative hair growth and scalp health](https://elevexo.com/wp-content/uploads/2025/12/Hair-Vials.png) ### Exosome Therapy for Hair Restoration Clinics Created for hair restoration clinics and dermatology practices, this formula targets follicular regeneration, anagen support, and scalp repair. [ Explore Elevexo® Hair ](https://elevexo.com/index.php/elevexo-hair/) ![Skin treatment injection vial for regenerative skin health and repair](https://elevexo.com/wp-content/uploads/2025/12/Skin-Vials.png) ## Exosome Therapy for Skin Rejuvenation Clinics Designed for medical aesthetics professionals, the formulation supports wrinkle reduction, collagen synthesis, hydration, and overall dermal resilience. [ Explore Elevexo® Skin ](https://elevexo.com/index.php/elevexo-skin/) ![Regenerative skin and hair treatment vials with packaging box for advanced therapy solutions](https://elevexo.com/wp-content/uploads/2025/12/EleveXo-2-1.png) ## Why Elevexo® Works The biology of hair and skin is dynamic influenced by vascular supply, structural proteins, cellular turnover, oxidative stress, and environmental damage. Elevexo® formulations integrate compounds that support: - Dermal and epidermal renewal - Vascular microcirculation - Collagen and extracellular matrix integrity - Hydration and barrier optimization - Follicle cycle activation and longevity ## Join Our Professional Distributor Network [ Become A Distributor ](https://regenomedix.com/distribution/) Elevexo partners with licensed professionals and medical distributors who want to bring science-driven hair and skin regeneration solutions to their networks. As an authorized distributor, you gain access to wholesale pricing, clinical education, marketing resources, and dedicated support designed to help you confidently introduce Elevexo formulations into professional settings. If you’re looking to expand your offerings or supply multiple clinics, Elevexo provides a structured, high-quality system to support your growth. --- ### [About](https://elevexo.com/about/) **Published:** December 1, 2025 **Author:** samowal faiz **Content:** ## About Elevexo® # The Science of Exosome Therapy — How Elevexo® Formulations Work Elevexo® is an FDA-compliant cosmetic Topical Product, ensuring safety and regulatory trust, designed to maximize the cell-signaling capabilities of exosomes, delivering the regenerative effects of amniotic fluid and Wharton’s Jelly via the [FDA-cleared NanoPen®](https://www.nanopen.pro/ "https://www.nanopen.pro/"). A topical cosmetic with unadulterated Exosomes derived from pure amniotic fluid suspension and umbilical cord Wharton’s Jelly. Averaging 70 billion protein particles carrying diverse exosome cargo such as miRNA, mRNA, proteins, lipids, growth factors, peptides, extracellular matrix components, collagens, and hyaluronic acid. Packaged in 5mL lyophilized vials, produced under cGMP and cGTP standards, with rigorous quality control systems and licensed across all relevant states to ensure consistent safety and quality. ![Regenerative skin and hair treatment vials with packaging box for advanced therapy solutions](https://elevexo.com/wp-content/uploads/2025/12/EleveXo-1.png) ## What Are Exosomes and Why Do They Matter in Regenerative Therapy? Exosomes are nanoscale extracellular vesicles released by cells to communicate with one another. Each carries a payload of growth factors, peptides, and signalling molecules that instruct surrounding cells how to repair, regenerate, and function. In regenerative medicine, this makes exosomes uniquely valuable: rather than delivering a single active ingredient, they transmit a coordinated set of biological signals that reflect the way the body naturally orchestrates healing. Elevexo® formulations are built on exosome therapy derived from MSC Wharton’s Jelly — a rich, well-characterised source of mesenchymal signalling factors. By harnessing these signals, exosome therapy supports the cellular processes behind healthy hair and skin renewal. Understanding what exosomes are and how they work is the foundation for understanding why Elevexo’s science-led approach is designed to support regeneration at the source, giving clinics an evidence-informed basis for their treatment protocols. ## Pharmaceutical-Grade Exosome Topical — Produced Under cGMP & cGTP Standards Elevexo® formulations are produced to pharmaceutical-grade standards, giving clinics confidence in both quality and consistency. Each exosome topical is manufactured under cGMP (current Good Manufacturing Practice) and cGTP (current Good Tissue Practice) standards, ensuring rigorous control at every stage of production. Every vial contains approximately 70 billion protein particles, delivered in a lyophilised (freeze-dried) format within 5mL vials to preserve stability and potency until the point of use. This manufacturing discipline reflects Elevexo’s commitment to trust, traceability, and clinical reliability. For licensed professionals, it means every formulation meets the exacting quality benchmarks expected of a regenerative product intended for use in a professional clinical environment. ## Elevexo®'s Scientific Framework for Exosome Therapy ### Growth Factor Signaling — How It Powers Hair & Skin Regeneration Growth factors work by supporting the natural communication between cells, helping coordinate the biological processes involved in healthy tissue maintenance and regeneration. Rather than acting independently, they interact with surrounding cells to support a balanced regenerative environment for both hair follicles and skin. In Elevexo® formulations, multiple growth factors are combined with complementary regenerative ingredients to create a science-driven approach for professional clinical use. This integrated strategy supports advanced hair restoration and skin rejuvenation protocols while aligning with the body's natural signaling mechanisms. ### Biomimetic Peptides — Engineered to Mimic Natural Biological Signals Biomimetic peptides are laboratory-designed molecules that imitate naturally occurring biological signals within the body. They are developed to support normal cellular communication by resembling the signaling mechanisms involved in tissue maintenance and repair. Because they are modeled after naturally occurring peptides, they can be incorporated into regenerative formulations designed for professional clinical use. Within Elevexo® formulations, biomimetic peptides complement growth factors by supporting coordinated cellular signaling. Together, these components contribute to a science-based approach focused on maintaining healthy hair follicles and supporting skin regeneration through advanced regenerative technology. ### Microenvironment Optimization — PDRN, Hyaluronic Acid & Adenosine A healthy cellular microenvironment plays an important role in supporting the natural regenerative processes of both hair follicles and skin tissue. Ingredients such as PDRN, hyaluronic acid, and adenosine are commonly used in regenerative formulations to help maintain hydration, support tissue quality, and create favorable conditions for normal cellular activity. Elevexo® combines these supportive ingredients to optimize the environment surrounding hair follicles and skin cells. By helping maintain moisture balance and supporting tissue integrity, these compounds complement the formulation's broader regenerative strategy and enhance its integration into professional clinical protocols. ### Synergistic Formulation Design — Every Ingredient Has a Role Effective regenerative formulations rely on the interaction of multiple ingredient categories rather than a single active component. Growth factors, biomimetic peptides, and supportive compounds each perform distinct functions, but together they create a more comprehensive regenerative approach. This coordinated design allows the formulation to address multiple aspects of cellular signaling and tissue support simultaneously. Elevexo® follows this synergistic formulation philosophy by combining scientifically selected ingredients into an integrated professional solution. The result is a balanced regenerative formulation designed to support advanced hair restoration and skin rejuvenation protocols in clinical settings. ## Clinical Integration — How Elevexo® Exosome Therapy Fits Your Practice Elevexo works closely with medical professionals to align each formulation with real-world procedural workflows. Both EleveXo H and EleveXo S complement in-clinic regenerative modalities, offering providers a structured, science-driven addition to their treatment protocols. --- ### [Elevexo Hair](https://elevexo.com/elevexo-hair/) **Published:** December 1, 2025 **Author:** samowal faiz **Content:** ## Elevexo® Hair ## Elevexo® H: Targeted Hair Regeneration Science # Exosome Hair Treatment for Follicle Repair & Scalp Restoration Elevexo® H is a regenerative hair formulation developed for dermatologists, aesthetic providers, and hair restoration clinics. Engineered with advanced **growth factors**, **biomimetic peptides**, and **supportive actives**, it addresses the cellular and vascular processes behind hair thinning and follicular dysfunction. This formulation is designed to support **hair follicle repair** and stimulate anagen phase extension, with early signs of improvement often seen within 6-8 weeks, encouraging patient optimism. ![Hair treatment injection vials for regenerative hair growth and scalp health](https://elevexo.com/wp-content/uploads/2025/12/Hair-Vials.png) ## How Exosome Hair Treatment Works — The Science Hair loss and thinning are often the result of reduced **follicular stem cell activity**, **vascular insufficiency**, **inflammation**, and **scalp aging**. Elevexo® H counteracts these factors with a synergistic blend of biologically active compounds: ## Hair Loss Treatment for Women & Men — How Elevexo® Helps Hair loss affects both women and men, but the underlying patterns and triggers often differ. In men, hair loss commonly follows a receding hairline and crown thinning driven largely by hormonal and genetic factors. In women, thinning tends to be more diffuse, spread across the scalp, and is frequently linked to hormonal shifts, stress, or age-related changes in follicle activity. Despite these differences, both share a common root: follicular dysfunction, where hair follicles gradually lose the signals needed to sustain healthy growth. Exosome therapy offers a treatment approach that addresses this shared root cause. By delivering concentrated growth factors and biomimetic peptides directly to the scalp, Elevexo® H supports the cellular environment around the follicle — helping to reactivate dormant follicles and extend the active growth phase. For clinics, this makes it a versatile hair loss treatment for women and men, suitable for a broad patient base from early-stage thinning to more advanced restoration cases. When identifying the best hair loss treatment for a given patient, exosome-based protocols stand out because they work at the biological level, supporting the follicle’s natural regenerative capacity rather than relying on temporary cosmetic effects. The clinical results shown on this page reflect outcomes achievable in a professional setting. ## Best Hair Loss Treatment for Follicular Regeneration For follicle-level hair loss, exosome-based treatment is increasingly regarded as one of the best hair loss treatment options available to clinics. Rather than targeting symptoms alone, it delivers regenerative signals directly to the follicular environment — supporting repair, improving the conditions for new growth, and helping to restore the follicle’s natural cycle. This targeted, biology-first approach is what distinguishes exosome therapy from conventional topical or oral solutions in professional hair restoration. ## Stem Cell Hair Restoration — The Elevexo® Approach Stem cell hair restoration is built on the principle that healthy follicles depend on active, well-signalled stem cell populations within the hair bulb. When these cells become dormant, hair growth slows and thinning follows. Elevexo® H supports this process through Stem Cell Factor (SCF, sh-Polypeptide-4) — a growth factor already included in the formulation that plays a key role in signalling and maintaining stem cell activity within the follicle. Rather than introducing external stem cells, the Elevexo® approach focuses on optimising the follicle’s own regenerative environment, encouraging resident stem cells to remain active and responsive. Combined with the formulation’s broader panel of growth factors and peptides, SCF helps create conditions that support natural follicular renewal. For clinics, this offers a science-backed, non-surgical pathway to stem cell hair restoration that complements existing protocols and aligns with growing demand for regenerative, stem cell–informed treatments. ## Microneedling Serum Protocol — Using Elevexo® H with Adjunct Procedures Microneedling creates controlled micro-channels in the scalp that temporarily enhance product absorption — making it an ideal companion procedure for regenerative formulations. As a microneedling serum, Elevexo® H is designed to be applied in conjunction with microneedling to help deliver growth factors and peptides more effectively into the treatment area. In clinical practice, Elevexo® H can be applied immediately following microneedling, when the scalp is most receptive, allowing the formulation’s active signals to reach the follicular environment. It also pairs well with PRP and other adjunct procedures as part of a comprehensive hair restoration protocol. Used this way, the formulation supports the scalp’s recovery while reinforcing the regenerative goals of the procedure, giving clinics a clear framework for integrating Elevexo® H into their combination-treatment workflows. ## Microneedling Aftercare Serum: Clinical Application Guide As a microneedling aftercare serum, Elevexo® H is applied by clinic staff immediately after the procedure and, where indicated, during the recovery window that follows. Once microneedling is complete, the treated area is cleansed and the formulation is applied evenly across the scalp, allowing the growth factors and peptides to absorb through the freshly created micro-channels. Clinics should follow their standard post-procedure protocols and advise patients on gentle aftercare to protect the treated area during healing. ## Growth Factors That Reactivate the Hair Cycle (IGF-1, VEGFA, Noggin, HGF, SCF) Hair growth is controlled by the cycle of follicles through anagen, catagen, and telogen phases. Disruption causes thinning and loss. Elevexo® H’s five growth factors stimulate dermal papilla cells, improve microcirculation, and prolong the anagen phase, directly supporting hair regeneration pathways. ## 1. IGF‑1 (sh‑Oligopeptide‑2) Insulin-Like Growth Factor‑1 (IGF‑1) plays a crucial role in maintaining the anagen phase and promoting follicular matrix cell proliferation.Studies show that reduced IGF‑1 levels are associated with impaired follicle cycling and thinning hair. By supplementing with a bioidentical analog, IGF‑1 supports follicle vitality and may enhance shaft thickness and density. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC12468416/). ## 2. VEGFA (sh‑Polypeptide‑9) Vascular Endothelial Growth Factor A (VEGFA) is a master regulator of angiogenesis around the hair follicle.Increased vascularization improves the delivery of oxygen and nutrients, which are essential for active follicle metabolism and sustained growth. VEGFA also supports perifollicular dermal health, helping prolong the anagen phase. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC199257/). ## 3. Noggin (sh‑Polypeptide‑13) Noggin is an antagonist of Bone Morphogenetic Proteins (BMPs), which suppress hair follicle development and maintenance.By inhibiting BMP signaling, Noggin helps activate and preserve follicular stem cells, promoting the transition from telogen to anagen. This mechanism is vital for reversing hair dormancy and reinitiating growth cycles. [Source](https://pubmed.ncbi.nlm.nih.gov/11641247/). ## 4. HGF (sh‑Polypeptide‑62) Hepatocyte Growth Factor (HGF) stimulates dermal papilla cell migration and proliferation. It also enhances perifollicular microcirculation, supporting oxygenation and nutrient exchange.HGF’s regenerative signaling contributes to hair shaft elongation and is associated with improved follicle structure and resilience. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC5101615/). ## 5. SCF (sh‑Polypeptide‑4) Stem Cell Factor (SCF) is essential for melanocyte survival and the health of follicular keratinocytes.It plays a role in maintaining hair pigmentation and follicular integrity, particularly under stress or aging conditions. SCF signaling also supports the follicle’s structural environment, promoting long-term hair viability. [Source](https://pubmed.ncbi.nlm.nih.gov/11259383/). ## Biomimetic Peptides for Follicle Repair (GHK-Cu, AHK-Cu, Phyto-NEP) These peptides are engineered to mimic biological messengers found in healthy hair follicles. They promote structural strength, follicle health, and scalp homeostasis. ## GHK‑Cu (Copper Tripeptide-1) Increases angiogenesis, collagen production, and follicle matrix activity. Shown to improve hair growth in in vitro and clinical studies. [Source](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073405/). ## AHK‑Cu (Copper Tripeptide-3) Works similarly to GHK-Cu, with more pronounced effects on follicular cell proliferation and visible improvements in hair density. [Source](https://pubmed.ncbi.nlm.nih.gov/17703734/). ## Phyto‑NEP (Caffeoyl sh‑Decapeptide‑9) A plant-derived neuroendocrine peptide designed to modulate inflammation, oxidative stress, and support scalp balance — key factors for optimal follicle function. ## Scalp Repair Actives — PDRN & Hyaluronic Acid ## PDRN (Polydeoxyribonucleotide) A DNA-based compound with strong regenerative capacity. Promotes angiogenesis, tissue repair, and fibroblast activation within the scalp, enhancing the environment for hair regrowth.[Source](https://www.sciencedirect.com/science/article/pii/S2096691122000723). ## Low‑Molecular‑Weight Hyaluronic Acid Improves scalp hydration, elasticity, and absorption of active ingredients. Maintains optimal follicular metabolism and supports dermal resilience. ## How Elevexo® H Supports Hair Restoration Together, these ingredients support key biological targets in hair loss management: - Reactivates **dormant follicles** - Extends the **anagen growth phase** - Enhances **blood supply** to hair roots - Protects against **oxidative and inflammatory damage** - Restores **scalp hydration and structural integrity** ## Who Is This Exosome Hair Treatment For? Elevexo® H is formulated for use by licensed professionals in: - Hair restoration clinics - Dermatology and trichology practices - Medical spas with advanced aesthetic protocols - Pre- and post-procedural scalp support (e.g., PRP, microneedling) ## Clinical Use, Application Protocol & Pairing Options - **Application**: Every 14 days with or without adjunct procedures - **Visible response**: Early improvement in texture or density within 6–8 weeks; ongoing results with continued use - **Pairing options**: Supports outcomes of LLLT, PRP, Stem Cells, Microneedling, and other regenerative therapies - **Safety**: All ingredients are backed by research, though patient evaluation is advised before treatment For clinics performing microneedling procedures, Elevexo® H can also be incorporated as a professional “microneedling serum” to complement post-treatment protocols. See the “Microneedling Serum Protocol” section above for recommended clinical application and aftercare guidance. ##### Results ##### Clinical Results — Exosome Hair Treatment Before & After Standard protocol: Two treatments separated by four weeks. Results shown at 90 days post first treatment. ![Women hair repair and nourishment concept](https://elevexo.com/wp-content/uploads/2026/03/hair-1-e1774631746909.jpg) ![Women hair restoration and growth concept](https://elevexo.com/wp-content/uploads/2026/02/hair-11-e1774631934386.png) ![Female hair care and treatment](https://elevexo.com/wp-content/uploads/2026/02/hair-4-e1774629521495.png) ![Healthy long female hair texture](https://elevexo.com/wp-content/uploads/2026/02/hair-44-e1774631585149.png) ![Female hair growth and strengthening treatment](https://elevexo.com/wp-content/uploads/2026/03/hair-61-e1774625670112.jpg) ![Soft and voluminous women hair](https://elevexo.com/wp-content/uploads/2026/03/hair-663-e1774626538500.jpg) --- ### [Elevexo® Skin](https://elevexo.com/elevexo-skin/) **Published:** December 1, 2025 **Author:** samowal faiz **Content:** ## Elevexo® Skin ## Elevexo® S : Science-Driven Skin Renewal # Exosome Skin Treatment & Growth Factor Serum for Skin Rejuvenation Elevexo® S is a professional-grade skin formulation designed for clinics, dermatologists, and aesthetic practitioners, offering scientifically grounded anti-aging care that delivers visible, evidence-based results. Developed with a precise combination of **growth factors**, **biomimetic peptides**, and **supporting actives**, Elevexo® S supports the biological processes behind smoother, firmer, and more resilient skin. ![Skin treatment injection vial for regenerative skin health and repair](https://elevexo.com/wp-content/uploads/2025/12/Skin-Vials.png) ## How Exosome Skin Treatment Works — The Science A decline in cell renewal, collagen production, vascularization, and hydration drives skin aging. Elevexo® S addresses these biological mechanisms through a multi-targeted approach: ## Exosomes for Skin — What the Research Shows Interest in exosomes for skin has grown rapidly as research continues to explore their role in regeneration and repair. Exosomes act as carriers of growth factors and signalling molecules that support the skin’s natural renewal processes — helping to promote a healthy environment for collagen production, hydration, and cellular turnover. Published research referenced on this page, including sources on EGF and PDRN, points to the regenerative potential of these signalling compounds when applied in a professional setting. As an exosomes skin treatment, Elevexo® S brings this science into clinical practice, combining a panel of growth factors and peptides selected for their supporting roles in skin regeneration. For clinics, this research-backed foundation strengthens both treatment rationale and patient confidence. ## Growth Factor Serum for Clinics — Key Benefits A professional growth factor serum is fundamentally different from the growth factor products marketed to consumers. Elevexo® S is formulated exclusively for clinical use, delivering a concentrated, standardised panel of growth factors and peptides at potencies appropriate for administration by licensed professionals. This makes it a reliable foundation for skin rejuvenation treatment protocols where consistency and quality are essential. For clinics, the key benefits are clear. First, professional-grade formulation: every batch is produced under strict manufacturing standards, ensuring predictable composition and performance. Second, targeted action: the serum’s growth factors and biomimetic peptides work together to support collagen synthesis, elasticity, and overall skin renewal. Third, protocol versatility: Elevexo® S integrates into a range of in-clinic treatments, from standalone application to combination procedures. Unlike consumer serums, which are limited by over-the-counter formulation constraints, a clinical growth factor serum is designed to complement professional procedures and deliver results that align with a clinic’s standards. For practices offering skin rejuvenation treatment, Elevexo® S provides a science-led, professional-tier option that supports both clinical outcomes and patient satisfaction. ### Collagen & Elastin Synthesis Collagen and elastin are the structural proteins responsible for skin firmness, elasticity, and a youthful appearance. Within the Elevexo® S formulation, growth factors such as EGF and IGF-1 play a supporting role in signalling the fibroblasts that drive collagen and elastin production. By reinforcing these natural signalling pathways — described in the growth factor section above — the serum helps support the skin’s structural renewal from within, contributing to improved texture, resilience, and tone over the course of a treatment protocol. ### 5 Growth Factors for Skin Rejuvenation Treatment (EGF, IGF-1, VEGFA, AFGF, BFGF) Growth factors are proteins that signal skin cells to grow, repair, and regenerate. Elevexo® S includes five clinically relevant growth factors: ## 1. EGF (sh‑Oligopeptide‑1) Epidermal Growth Factor (EGF) binds to the EGF receptor (EGFR) on keratinocytes and dermal fibroblasts, thereby promoting cell survival, proliferation, migration, and differentiation. Clinical/interface data show topical EGF can accelerate re‑epithelialization, improve skin texture, and reduce signs of ageing. In the context of wrinkle reduction, activating fibroblasts and improving collagen matrix synthesis address one of the core deficits of aged skin. [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC10333026/). ## 2. IGF‑1 (sh‑Oligopeptide‑2) Insulin‑like Growth Factor‑1 (IGF‑1) signaling in skin has been shown to decline with age; lower IGF‑1 is associated with epidermal atrophy and increased keratinocyte damage. By supplying a bio‑mimetic analog of IGF‑1, the formulation supports fibroblast anabolic activity, enhances ECM production, and may improve dermal thickness—key for wrinkle amelioration. [Source](https://www.researchgate.net/publication/235384607_Serum_insulin-like_growth_factor_1_and_facial_ageing_High_levels_associate_with_reduced_skin_wrinkling_in_a_cross-sectional_study). ## 3. VEGFA (sh‑Polypeptide‑9) Vascular Endothelial Growth Factor A (VEGFA) is essential for angiogenesis and the maintenance of the skin microvasculature; evidence shows that VEGFA signaling enhances nutrient and oxygen delivery, supporting fibroblast viability and extracellular matrix turnover, making it a key target in skin rejuvenation therapies. ## 4. AFGF (sh‑Polypeptide‑11) Acidic Fibroblast Growth Factor (aFGF) has been implicated in dermal repair and regeneration in the wound-healing literature; although less direct in aesthetic dermatology, its inclusion supports fibroblast proliferation and collagen/elastin synthesis in synergy with other growth factors. ## 5. BFGF (sh‑Polypeptide‑1) Basic Fibroblast Growth Factor (bFGF) similarly acts on dermal fibroblasts, promoting collagen and glycosaminoglycan (GAG) production. Its role in enhancing dermal matrix density complements the overall strategy of restoring skin structural integrity. ### Biomimetic Peptides for Skin Repair (GHK-Cu, AHP, Phyto-NEP) These lab-engineered peptides replicate signals naturally found in the skin, enhancing its ability to repair and rebuild. ## GHK-Cu (Copper Tripeptide-1) A potent skin-regenerating peptide that boosts collagen, elastin, and glycosaminoglycan production. [Source.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073405/) ## AHP (Acetyl Hexapeptide-8) Often referred to as a “topical Botox mimic”, AHP reduces the appearance of expression lines by relaxing facial tension. ## Phyto-NEP (Caffeoyl sh-Decapeptide-9) A plant-derived peptide that enhances skin defense mechanisms and promotes a smoother texture. ### Supporting Actives — Hyaluronic Acid, Adenosine, PDRN These compounds complement the growth factors and peptides, helping create a healthy environment for regeneration. ## Low‑Molecular‑Weight Hyaluronic Acid Hydration and volume loss are intrinsic to skin ageing: low‑molecular‑weight hyaluronic acid penetrates more deeply, binds water, improves dermal turgor, and creates an optimal milieu for fibroblast activity. ## Adenosine Adenosine interacts with purinergic receptors in the dermis and epidermis, influencing collagen production and microcirculatory tone, and may improve wrinkle appearance in controlled studies. ## PDRN (Polydeoxyribonucleotide) Polydeoxyribonucleotide (PDRN) is a nucleic acid derivative that has been shown to accelerate fibroblast and keratinocyte proliferation, enhance angiogenesis, and improve dermal repair in skin models. Its incorporation provides a “regeneration priming” effect, supporting the actions of growth factors and peptides. [Source](https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0034-1372423.pdf). ## Exosomes Skin Treatment Protocol — Synergistic Action By combining these components, Elevexo® S addresses skin aging through: - Collagen and elastin production - Cell turnover acceleration - Improved hydration and barrier function - Microcirculation enhancement - Relaxation of dynamic lines ## Who Uses Elevexo® S? Clinics, Med Spas & Aesthetic Practitioners Elevexo® S is designed for use in medical aesthetics settings, including: - Dermatology and anti-aging clinics - Med spas with licensed professionals - Post-procedural skin repair protocols - Integration with microneedling, RF, or laser treatments ### Clinical Use & Application - **Suggested use**: Every 14-day application, with or without adjunct procedures - **Visible effects**: Improved texture, tone, and hydration typically observed in 4–8 weeks - **Professional guidance recommended** - **No systemic claims or permanent outcomes** ## Microneedling Serum Protocol — Elevexo® S as a Clinical Enhancer Microneedling is one of the most widely used procedures in aesthetic practice, and pairing it with the right serum can significantly enhance its regenerative value. As a microneedling serum, Elevexo® S is designed to work alongside microneedling, RF microneedling, and laser resurfacing — procedures already referenced in the Clinical Use section of this page. When applied pre- or post-procedure, Elevexo® S delivers growth factors and peptides into the skin at a time when absorption is optimised. Applied beforehand, it primes the skin with regenerative signals; applied afterward, it supports recovery and reinforces the treatment’s rejuvenating effects. This dual role makes the serum a flexible enhancer across a clinic’s existing device-based treatments, giving practitioners a straightforward way to elevate outcomes while supporting the skin’s natural healing response following controlled micro-injury. ### Microneedling Aftercare Serum: Application Guide for Clinics As a microneedling aftercare serum, Elevexo® S is applied by clinic staff once the procedure is complete. After cleansing the treated area, the serum is applied evenly across the skin, allowing the active signals to absorb through the micro-channels created during treatment. Clinics should incorporate application into their standard post-procedure routine and provide patients with clear aftercare guidance to protect and support the skin during the initial recovery period ##### Results ##### Clinical Results — Skin Rejuvenation Treatment Before & After Standard protocol: Two treatments separated by four weeks. Results shown at 60 days post first treatment. ![Men skin care treatment close-up](https://elevexo.com/wp-content/uploads/2026/02/skin-6.png) ![Clear and smooth male skin appearance](https://elevexo.com/wp-content/uploads/2026/02/skin-66.png) ![Men skin rejuvenation and skincare concept](https://elevexo.com/wp-content/uploads/2026/02/skin-77.png) ![Clear and smooth male skin appearance](https://elevexo.com/wp-content/uploads/2026/02/skin-7.png) ![Female skin care treatment close-up](https://elevexo.com/wp-content/uploads/2026/02/skin-2.png) ![Smooth and glowing female skin](https://elevexo.com/wp-content/uploads/2026/02/skin-22.png) --- ### [Exosome vs PRP for Hair Loss](https://elevexo.com/exosome-vs-prp-hair/) **Published:** July 6, 2026 **Author:** samowal faiz **Content:** # Exosome vs PRP for Hair Loss ## Exosome vs PRP for Hair Loss: A Clinical Comparison Androgenetic alopecia (AGA) impacts approximately 50% of men by the age of 50. It affects millions of women globally, culminating in the gradual miniaturization of hair follicles, a decline in hair density, and considerable psychological distress. Although topical minoxidil and oral finasteride remain the main therapeutic options, they require continuous administration and often yield modest results. Recently, [two biologic](#!/) therapies—platelet-rich plasma (PRP) and exosome therapy—have been introduced as promising regenerative alternatives for patients seeking more effective, non-surgical solutions. For clinicians and patients evaluating exosome therapy versus platelet-rich plasma (PRP) for hair treatment, understanding the differences in mechanisms, effectiveness, recovery time, and durability is crucial. This guide provides an evidence-based comparison to support informed decision-making. ![Medic wearing gloves uses a handheld device to inject into a man's scalp during a hair treatment.](https://elevexo.com/wp-content/uploads/2026/07/exmine-1024x683.jpg) ## Mechanism of Action: How Each Treatment Works ### PRP for Hair Restoration PRP is derived from the patient’s own blood. A modest volume is procured, centrifuged to concentrate platelets, and then administered into the scalp. Platelets encompass a [range of growth factors](https://rjsvd.com/1560-9588/article/view/702085) (including PDGF, VEGF, TGF-β1, and IGF-1) that stimulate quiescent hair follicles, prolong the anagen (growth) phase, and improve sanguineous flow to the scalp. A 2025 systematic review and meta-analysis of 43 randomized controlled trials (1,877 participants) concluded that PRP is [safe and effective](https://clinicaltrials.gov/study/NCT06239207) in improving hair density and reducing hair loss. However, it did not significantly affect hair thickness. ### Exosome Therapy for Hair Loss Exosomes are nanoscale extracellular vesicles ranging from 30 to 150 nanometers in size that are secreted by mesenchymal stem cells (MSCs). They encompass a diverse array of bioactive molecules, including growth factors, proteins, lipids, mRNA, and microRNAs (miRNAs), which facilitate intercellular communication and directly target hair follicle stem cells. In contrast to PRP, exosome therapy does not require a blood draw or injection. Instead, professionally formulated topical exosome products, such as EleveXo®, are applied to the scalp, often after microneedling to enhance penetration. Research has shown that [exosomes work](https://tressless.com/community/koshine-kx_826-my-experience-after-2-months-yes-its-working-YJ78) through multiple pathways: - Delivering growth factors directly to dormant follicles - Modulating inflammation by reducing pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β - Promoting angiogenesis via the PI3K/Akt-VEGFA axis, restoring the follicular vascular niche - Activating hair follicle stem cells through Wnt/β-catenin, Shh, and HIF-1α signaling pathways A 2025 [systematic review](https://www.mdpi.com/2076-3271/14/1/5) of 11 clinical studies, including 2 randomized controlled trials (RCTs), concluded that mesenchymal stem cell (MSC)-derived exosomes appear to be a safe and efficacious treatment for androgenetic alopecia (AGA) and other forms of alopecia, with high patient satisfaction. ## Clinical Evidence: Head-to-Head Comparisons ### Randomized Controlled Trial: Salmon Tissue-Derived Exosomes vs PRP A prospective randomized controlled trial scheduled for 2026 involved 40 participants diagnosed with mild-to-moderate androgenetic alopecia (AGA). The study compared the efficacy of salmon tissue-derived exosomes, administered across four sessions, with platelet-rich plasma (PRP) therapy, administered over five sessions. At the 12-week assessment, the group receiving exosomes demonstrated significantly superior improvements across all evaluated parameters. ****Parameter**** ****Exosome Group**** ****PRP Group**** ****Difference (p-value)**** [Hair density increase](https://elevexo.com/elevexo-hair/) +44.4 hairs/cm² +26.3 hairs/cm² +18.1 (p<0.001) Vellus hair reduction –37.0% –21.2% (p=0.003) Terminal/vellus ratio 2.4 → 9.7 → 4.8 (p=0.001) Anagen proportion increase +36.4% +23.4% (p=0.002) Mean hair diameter increase +22.4μm +13.1μm (p<0.05) The trial showed that exosomes had statistically significant benefits over Platelet-Rich Plasma (PRP) in most measured parameters, even with fewer treatment sessions. ## Randomized Controlled Trial: Salmon Tissue-Derived Exosomes vs PRP ****Feature**** ****Exosome Therapy**** ****PRP Treatment**** ****Source**** Lab-cultured mesenchymal stem cells Patient’s own blood ****Growth factor concentration**** Higher, standardized potency Variable, depends on patient health ****Procedure time**** 30-45 minutes 60-90 minutes (plus blood draw) ****Pain level**** Minimal Mild to moderate ****Recovery time**** Immediate 1-2 days ****Results timeline**** 1-3 months 3-6 months ****Number of sessions**** 1-2 sessions 3-4 sessions ****Longevity of results**** 12-18 months 8-14 months ****Consistency**** Standardized across patients Varies based on patient biology ****FDA-compliant cosmetic status**** Yes (EleveXo™ and Ascellos®) Not applicable ## Longevity and Maintenance Longevity is a key consideration when comparing exosome and PRP hair treatments. Since exosomes deliver a concentrated, standardized set of growth factors and genetic material directly to hair follicle stem cells, they tend to offer a longer-lasting regenerative effect. Clinical data indicate that exosome therapy effects typically last between 12 and 18 months, while PRP outcomes usually persist for 8 to 14 months. Both treatments can be extended with periodic maintenance sessions. ### Clinical Suitability ****Patient Profile**** ****Recommended Approach**** ****Rationale**** Early-stage hair thinning Exosome therapy Fewer sessions, faster results, longer durability Moderate-to-severe AGA Exosome therapy (primary) or PRP (alternative) Exosomes show superior efficacy in advanced cases Patients with poor blood quality (anemia, etc.) Exosome therapy Does not depend on the patient’s own blood quality Budget-sensitive patients PRP Lower cost per session, though more sessions are needed Patients preferring autologous treatment PRP Uses the patient’s own biological material ## Can Exosome and PRP Treatments Be Combined? Some protocols combine PRP with exosome therapy to enhance results. PRP’s growth factors prepare the scalp, while exosomes provide a wider range of regenerative signals. This approach is especially helpful for patients with severe hair loss who haven’t improved with single treatments. Clinical data indicate that exosome therapy effects typically last between 12 and 18 months, while PRP outcomes usually persist for 8 to 14 months. Both treatments can be extended with periodic maintenance sessions. ## Frequently Asked Questions Are exosomes better than PRP for hair loss? Current clinical evidence, including a systematic review from 2025 and a randomized controlled trial from 2026, indicates that exosome therapy is more effective than PRP in increasing hair density, reducing vellus hair, improving the terminal-to-vellus hair ratio and anagen proportion, and boosting patient satisfaction. Moreover, exosome therapy needs fewer sessions and provides longer-lasting results. How long do exosome hair treatment results last? Results typically last 12-18 months. Occasional maintenance sessions (once or twice a year) can extend the benefits indefinitely. Is exosome therapy painful? Most patients experience little discomfort, particularly when the procedure is combined with anesthetic cream or microneedling. There is no pain linked to the injections. Who is a good candidate for exosome hair therapy? Men and women with early to moderate androgenetic alopecia (AGA), stress-related hair loss (telogen effluvium), or who have not responded well to minoxidil or finasteride might consider exosome therapy. Additionally, exosomes offer a good alternative for patients wanting fewer treatments and faster results. ## Ready to offer advanced exosome hair restoration? ****EleveXo™**** offers professionally developed MSC-derived exosome products for hair and skin regeneration. Every batch is manufactured in accordance with cGMP and cGTP standards and undergoes thorough quality control. Partner with our licensed clinics and medical distributors to provide science-based regenerative treatments to your patients. [ Become an EleveXo ](https://regenomedix.com/distribution/) ****Disclaimer:**** This content is for educational and informational use only, based on published scientific literature. EleveXo™ is a cosmetic topical that complies with FDA regulations. It is not meant to diagnose, treat, cure, or prevent any medical conditions. Always seek advice from a qualified healthcare professional for medical guidance. --- ### [Clinics & Wholesale Partners](https://elevexo.com/for-clinics/) **Published:** July 6, 2026 **Author:** samowal faiz **Content:** # Clinics & Wholesale Partners ## For Clinics & Wholesale Partners EleveXo™ creates professional topical formulations designed specifically for licensed medical practices. Our products incorporate clinically supported growth factors, biomimetic peptides, and exosome technology to support hair restoration and skin rejuvenation. We supply these exclusively to qualified clinics and distributors committed to science-based, compliant regenerative therapies. ### Who This Page Is For - **Licensed aesthetic clinics****offering advanced skin and hair treatments - **Hair restoration practices****integrating non-invasive regenerative protocols - **Dermatology professionals****seeking evidence-based topical formulations - **Medical spas****adding exosome-enhanced services to their menu - **Wholesale distributors****supplying premium regenerative products to the professional channel ![Medical doctor with stethoscope shakes hands with a storage-ward staff member in a pharmaceutical warehouse aisle in agreement.](https://elevexo.com/wp-content/uploads/2026/07/wholesale.jpg) ## What You Receive ### Professional Formulations EleveXo products incorporate a proprietary mixture of exosomes (70 billion particles per vial), growth factors including EGF, IGF-1, VEGFA, aFGF, and bFGF, as well as peptides such as GHK-Cu, acetyl hexapeptide-8, and palmitoyl tetrapeptide-7. The formulation further comprises supportive active constituents like PDRN, hyaluronic acid, and adenosine. Each batch undergoes meticulous standardization to ensure consistent potency and purity. ### Clinical Manufacturing Process EleveXo products are processed in a cGMP-compliant environment at an FDA-registered laboratory that has been third-party validated for particle count, bioactivity, and sterilization, and holds comprehensive certification. The laboratory is accredited by the American Association of Tissue Banks (AATB). ### Distributor Support We offer wholesale pricing, clinical education materials, marketing resources (such as patient handouts, social media assets, and website content), and dedicated account management. Together, we’ll create engaging programs to help your business grow steadily. ### Regulatory Compliance EleveXo is a topical cosmetic that adheres to FDA regulations and is produced under Current Good Manufacturing Practices (cGMP) and Current Good Tissue Practices (cGTP). The FDA-registered and licensed manufacturing facility operates across all relevant states. ## Why EleveXo? Science & Quality at Every Step ### Exosome-Powered Regeneration Exosomes are naturally occurring extracellular vesicles that carry miRNA, mRNA, proteins, and lipids to target cells. Research has shown their [ability to stimulate follicle stem cells](https://pmc.ncbi.nlm.nih.gov/articles/PMC12433634/), promote angiogenesis, and reduce inflammation. In contrast to PRP, exosome therapy relies less on the patient’s blood quality, enabling more consistent outcomes across batches of standardized exosomes. ### Transparent Sourcing We obtain our exosomes from ethically sourced, cGMP-compliant amniotic fluid and umbilical cord (Wharton’s Jelly) products. Each batch is tested for purity, potency, and the absence of endotoxin. ### Proven Growth Factors & Peptides - **EGF****(sh-Oligopeptide-1) might [accelerate re-epithelialization](https://pubmed.ncbi.nlm.nih.gov/37452558/) and improve skin texture. - **IGF-1****(sh-Oligopeptide-2) supports [fibroblast anabolic activity](https://elevexo.com/elevexo-skin/) and dermal thickness. - **VEGFA****(sh-Polypeptide-9) enhances microcirculation and [nutrient delivery](https://pubmed.ncbi.nlm.nih.gov/26662923/). - **GHK-Cu****(copper tripeptide-1) boosts collagen, elastin, and [glycosaminoglycan production](https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/). ### cGMP & cGTP Certification All EleveXo products are manufactured in a facility that meets cGMP[ (pharmaceutical-grade) and cGTP (tissue-product) standards](https://elevexo.com/about/), ensuring reproducible quality and safety. The facility is also AATB-accredited and FDA-registered as a tissue establishment ### Compliance with Florida Stem Cell Law In accordance with Florida SB 1768/HB 1617, effective July 1, 2025, licensed physicians may administer certain regenerative biologics that are not FDA-approved under specified conditions. We aspire to have Exosomes included on the list of approved products in the near future. In anticipation of this development, all of our products are meticulously formulated to meet these regulatory standards, thereby offering clinicians a compliant pathway for providing exosome-based therapies. ### Wholesale Inquiry Process 1. **Submit a request****through our wholesale inquiry form (below). 2. **Credential verification****. We verify that all distribution partners are licensed medical professionals or established wholesale distributors. 3. **Choose your distribution model****—Independent representative, stocking distributor, or white-label/private label partnership. 4. **Sign the agreement****. Outline pricing, territory, and support terms. 5. **Receive onboarding****: product training, marketing assets, and ongoing clinical support. ## Frequently Asked Questions Do I need to be a licensed clinic to purchase EleveXo? Yes. EleveXo™ is a line designated for professional use. We exclusively supply licensed medical practices and authorized wholesale distributors. What is the minimum order quantity? There is no minimum for qualified clinics. Wholesale and distributor agreements have negotiated volume tiers. How do I become a distributor? Complete the wholesale inquiry form. We will contact you within 2-3 business days to discuss a partnership. Does EleveXo™ offer white-label options? Yes. We provide private-label and white-label manufacturing for established distributors # Ready to Partner with EleveXo? Join our network of regenerative medicine professionals and bring premium exosome formulations to your practice or distribution portfolio. [ Apply for Wholesale Access ](https://regenomedix.com/distribution/) For immediate questions, contact our wholesale team at [****info@regenomedix.com****](mailto:info@regenomedix.com) or call [****(561) 325-7000****](tel:5613257000). ****Disclaimer:**** EleveXo® is a topical cosmetic that meets FDA standards. It is not intended to diagnose, treat, cure, or prevent any health conditions. Use only as advised by a licensed healthcare provider. --- ### [Contact](https://elevexo.com/contact/) **Published:** December 1, 2025 **Author:** samowal faiz **Content:** # Contact Elevexo® — Clinic Distribution & Wholesale Inquiries ## Hair Restoration Products for Clinics — Wholesale & Distribution Elevexo® supplies professional hair restoration products for clinics directly to licensed practices across the United States. As a B2B regenerative brand, we work exclusively with aesthetic clinics, hair restoration practices, and dermatology professionals — providing the formulations, documentation, and support they need to deliver advanced treatments with confidence. Our wholesale program gives clinics access to medical grade hair products developed specifically for professional use, backed by clinical documentation and distributor support. Whether you are adding exosome therapy to your existing service menu or building a dedicated hair restoration offering, our team can help you get started. For clinics seeking hair growth products wholesale, Elevexo® offers a straightforward path to partnership — from initial inquiry through to ongoing supply. Use the form below to reach our distribution team and learn more about becoming an Elevexo® clinical partner. ### Medical Grade Hair Products Available to Licensed Professionals Medical grade hair products are professional-tier formulations produced to clinical standards and intended for administration by qualified practitioners. Elevexo® products are available exclusively to licensed professionals and clinics — including aesthetic providers, hair restoration specialists, and dermatology practices — ensuring every treatment is delivered within an appropriate professional setting and supported by proper clinical oversight. ### Hair Growth Products Wholesale — Pricing & Access For hair growth products wholesale pricing and account access, our distribution team is ready to help. Elevexo® works with each clinic individually to establish wholesale terms suited to their volume and treatment needs. To request pricing, product documentation, or to open a wholesale account, simply complete the contact form below and a member of our team will be in touch. ## Serving Hair Restoration Clinics Across the US From our base in Boca Raton, Florida, Elevexo® serves hair restoration clinics nationwide. Our distribution network supports licensed practices across the United States, including major metropolitan markets such as Chicago, Houston, Los Angeles, and Miami. Wherever your clinic is located, our team can coordinate supply, documentation, and onboarding to help you integrate Elevexo®’s regenerative formulations into your practice. Reach out to learn how we support clinics in your region. ### Hair Loss Treatment Clinics in Chicago, Houston, Los Angeles & Miami Elevexo® partners with hair loss treatment clinics in Chicago, Houston, Los Angeles, and Miami, as well as practices in cities across the country. If your clinic operates in one of these markets — or anywhere in the US — and is interested in offering exosome-based hair restoration, we’d love to hear from you. Use the contact form below to connect with our distribution team. ## Get in Touch [ ](tel:5613257000) ### [ Call Us ](tel:5613257000) ## [561-325-7000](tel:5613257000) [ ](mailto:support@elevexo.com) ### [ Mail Us ](mailto:support@elevexo.com) ## ### Address ## [141 NW 20th St. Suite G1, Boca Raton, FL 33431 USA](https://share.google/GyyUJPklzjh8MJcoT) # Interested in Distribution? [ Become A Distributor ](https://regenomedix.com/distribution/) Elevexo® partners with licensed professionals and medical distributors who want to bring science-driven hair and skin regeneration solutions to their networks. As an authorized distributor, you gain access to wholesale pricing, clinical education, marketing resources, and dedicated support designed to help you confidently introduce Elevexo formulations into professional settings. If you’re looking to expand your offerings or supply multiple clinics, Elevexo provides a structured, high-quality system to support your growth. --- ### [Blogs](https://elevexo.com/blogs/) **Published:** July 6, 2026 **Author:** samowal faiz **Content:** ## Blogs ✕ Search [ View all results for "" ](#) [![Precision dropper applying serum to the scalp, representing growth factor delivery and hair regeneration research](https://elevexo.com/wp-content/uploads/2026/07/Picture1.png)](https://elevexo.com/growth-factors-in-hair-regeneration-understanding-the-signaling-pathways/)Blogs ### [ Growth Factors in Hair Regeneration: Understanding the Signaling Pathways ](https://elevexo.com/growth-factors-in-hair-regeneration-understanding-the-signaling-pathways/) Hair follicles are intricate mini-organisms that undergo cyclical phases of growth (anagen), regression (catagen), and rest (telogen). [ Read More » ](https://elevexo.com/growth-factors-in-hair-regeneration-understanding-the-signaling-pathways/) July 6, 2026 No Comments [![Healthy skin on a person's back represents skin renewal, repair, and regenerative signaling pathways.](https://elevexo.com/wp-content/uploads/2026/07/Picture1.pngfdsg.png)](https://elevexo.com/growth-factors-in-skin-renewal-understanding-the-signaling-network/)Elevexo Skin ### [ Growth Factors in Skin Renewal: Understanding the Signaling Network ](https://elevexo.com/growth-factors-in-skin-renewal-understanding-the-signaling-network/) The skin is the body’s largest organ and functions as the primary interface between the internal environment [ Read More » ](https://elevexo.com/growth-factors-in-skin-renewal-understanding-the-signaling-network/) July 6, 2026 No Comments [![Woman applying skincare cream, representing biomimetic peptide activity in skin signaling and renewal.](https://elevexo.com/wp-content/uploads/2026/07/Picture1.pngd_.png)](https://elevexo.com/biomimetic-peptides-mechanisms-of-signal-collagen-and-inflammation/)Blogs ### [ Biomimetic Peptides: Mechanisms of Signal, Collagen, and Inflammation ](https://elevexo.com/biomimetic-peptides-mechanisms-of-signal-collagen-and-inflammation/) Biomimetic peptides are synthetic molecules engineered to mimic the structure and function of naturally occurring peptide fragments. [ Read More » ](https://elevexo.com/biomimetic-peptides-mechanisms-of-signal-collagen-and-inflammation/) July 6, 2026 No Comments [![Woman relaxing during a facial treatment as a clinician with pink gloves holds her face gently with hands on cheeks and temples](https://elevexo.com/wp-content/uploads/2026/07/Picture1.png11.png)](https://elevexo.com/low-molecular-weight-hyaluronic-acid-for-skin-and-hair-research-overview/)Blogs ### [ Low-Molecular-Weight Hyaluronic Acid for Skin and Hair: Research Overview ](https://elevexo.com/low-molecular-weight-hyaluronic-acid-for-skin-and-hair-research-overview/) Hyaluronic acid is well known for its remarkable moisture-retaining properties, but its biological effects extend beyond hydration [ Read More » ](https://elevexo.com/low-molecular-weight-hyaluronic-acid-for-skin-and-hair-research-overview/) July 6, 2026 No Comments [![Woman applying hand cream representing tissue repair, skin regeneration, and restorative biological processes.](https://elevexo.com/wp-content/uploads/2026/07/Picture1.png111.png)](https://elevexo.com/pdrn-in-tissue-repair-regenerative-mechanisms-and-clinical-applications/)Blogs ### [ PDRN in Tissue Repair: Regenerative Mechanisms and Clinical Applications ](https://elevexo.com/pdrn-in-tissue-repair-regenerative-mechanisms-and-clinical-applications/) The regenerative effects of PDRN have been most thoroughly examined in skin repair. Both preclinical and clinical [ Read More » ](https://elevexo.com/pdrn-in-tissue-repair-regenerative-mechanisms-and-clinical-applications/) July 6, 2026 No Comments [![Hair and Skin Regeneration](https://elevexo.com/wp-content/uploads/2026/07/Picture1.pngdfsdag.png)](https://elevexo.com/adenosine-and-its-role-in-regeneration/)Blogs ### [ Adenosine and Its Role in Regeneration ](https://elevexo.com/adenosine-and-its-role-in-regeneration/) Adenosine is a naturally occurring nucleoside present in all human cells. It serves as a fundamental component [ Read More » ](https://elevexo.com/adenosine-and-its-role-in-regeneration/) July 6, 2026 No Comments --- ### [Privacy Policy](https://elevexo.com/privacy-policy/) **Published:** December 8, 2025 **Author:** samowal faiz **Content:** # Privacy Policy [Home](https://elevexo.com) » Privacy Policy *Last Updated: January 2025* Welcome to **Elevexo**. Your privacy is important to us. This Privacy Policy explains how we collect, use, store, and safeguard information when you visit our website [**https://elevexo.com/**](https://elevexo.com/) or interact with us through our contact forms, email, or phone. By using this website, you agree to the terms described below. If you do not agree, please discontinue use immediately. **Who We Are** Elevexo provides science-driven educational information on regenerative formulations for hair and skin health. Our contact details: **Elevexo** 141 NW 20th St. Suite G1, Boca Raton, FL 33431, USA Email: [**info@elevexo.com**](mailto:info@elevexo.com) Phone: **561-325-7000** **Information We Collect** We collect two types of information: **Information You Provide Voluntarily** When you submit a form, contact us, or request information, you may provide: - First Name & Last Name - Email Address - Phone Number - Message or Inquiry Details This information is used only for communication and customer support purposes. **Information Collected Automatically** When you browse our website, we may collect technical and usage data such as: - IP address - Browser type - Device type - Pages visited - Time spent on the website - Referring website or link This data is used for analytics, security, and website performance improvement. **Cookies & Tracking Technologies** Our website may use cookies or similar technologies to: - Improve functionality - Enhance user experience - Analyze website traffic You may disable cookies through your browser settings, though some features of the site may not function properly. **How We Use Your Information** Elevexo uses collected information for: - Responding to inquiries submitted via the Contact page - Providing customer support and communication - Improving website performance, design, and security - Understanding and analyzing website usage - Administrative and operational purposes We **do not use your data for medical, diagnostic, or treatment purposes.** **How We Share Your Information** We do **not sell**, rent, or trade personal information. We may share limited information only with trusted third-party providers who assist with: - Website hosting - Email delivery - Security and analytics - Form processing These providers are obligated to maintain confidentiality and cannot use your information for any purpose other than providing agreed-upon services. We may also disclose information if required to comply with applicable laws, legal processes, or governmental requests. **Data Storage & Security** We take reasonable technical and organizational measures to safeguard your information from unauthorized access, alteration, disclosure, or destruction. However, no online transmission or electronic system is 100% secure. You acknowledge that you provide information at your own risk. **Data Retention** We retain collected information only as long as needed for: - Communication and support - Website performance and analytics - Legal compliance Once information is no longer required, we securely delete or anonymize it. **Your Rights** Depending on your location, you may have the right to: - Request access to the personal data we hold - Request correction or updates - Request deletion of your information - Withdraw consent (when applicable) - Restrict or object to certain forms of data processing To exercise these rights, contact us at [**info@elevexo.com**](mailto:info@elevexo.com). **Third-Party Links** Our website may contain links to external websites such as scientific sources, partner pages, or informational resources. We are **not responsible** for the privacy practices, content, or security of external sites. **Children’s Privacy** Elevexo does **not** knowingly collect information from individuals under 13 years of age. If we learn that we have collected data from a child under 13, we will remove it promptly. **Medical & FDA Disclaimer** Elevexo provides **educational information only**. Nothing on this website is intended to: - Diagnose, treat, cure, or prevent any disease - Replace medical advice - Serve as physician consultation These statements have not been evaluated by the FDA. **International Visitors** If you access our site from outside the United States, your information may be transferred and processed according to U.S. laws, which may differ from your country’s data protection standards. **Changes to This Privacy Policy** We may update this Policy periodically. When updated, the “Last Updated” date at the top will reflect the change. Continued use of the website after changes indicates acceptance of the revised policy. **Contact Us** For questions, data requests, or concerns regarding this Privacy Policy, you may contact us at: **Email:** **Phone:** 561-325-7000 **Address:** 141 NW 20th St. Suite G1, Boca Raton, FL 33431, USA --- ## Categories ### [Blogs](https://elevexo.com/category/blogs/) --- ### [Elevexo Skin](https://elevexo.com/category/elevexo-skin/) ---